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Temperate phages are pervasive in bacterial genomes, existing as vertically-inherited islands called 3 
prophages. Prophages are vulnerable to the predation of their host bacterium by exogenous phages. 4 
Here we identify BstA, a novel family of prophage-encoded phage defence proteins found in diverse 5 
Gram-negative bacteria. BstA drives potent suppression of phage epidemics through abortive infection. 6 
The bstA-encoding prophage itself is not inhibited by BstA during lytic replication due to a self-immunity 7 
mechanism driven by the anti-BstA (aba) element, a short stretch of DNA within the bstA locus. Phage-8 
targeting by distinct BstA proteins from Salmonella, Klebsiella and Escherichia prophages is functionally 9 
interchangeable, but each possesses a cognate aba element. The specificity of the aba element ensures 10 
that immunity is exclusive to the replicating prophage, and cannot be exploited by heterologous BstA-11 
encoding phages. BstA allows prophages to defend their host cells against exogenous phage attack, 12 




The perpetual battle between bacteria and their viruses (phages) has driven the evolution of a diverse 17 
array of phage defence systems in bacteria (Bernheim and Sorek, 2020; Hampton et al., 2020; Houte 18 
et al., 2016; Rostøl and Marraffini, 2019. Conversely, it is increasingly recognised that phages have 19 
evolved many mechanisms to subvert these defence systems (Maxwell, 2017; Samson et al., 2013; 20 
Trasanidou et al., 2019). Though perhaps the most intuitive form of phage defence involves the direct 21 
rescue of an infected cell, for example by the targeted degradation of phage nucleic acids by CRISPR-22 
Cas, or restriction modification systems, many phage-defence systems in fact function solely at the 23 
population level. In a mechanism conceptually analogous to the pathogen-stimulated programmed cell 24 
death driven by the innate immune systems of higher organisms (Abedon, 2012), population-level 25 
defence systems prevent phage infection spreading across entire populations, at the cost of the lives of 26 
infected cells. 27 
 28 
Population-level phage defence systems are often grouped under the umbrella term “abortive infection” 29 
(Abi) (Labrie et al., 2010; Lopatina et al., 2020) and represent diverse mechanisms to prevent phage 30 
replication and cause cell death. These include protease-mediated inhibition of cellular translation 31 
(Bingham et al., 2000), toxin-antitoxin pairs (Fineran et al., 2009) and cyclic oligonucleotide signalling 32 
(Cohen et al., 2019). Recently, it has been proposed that certain CRISPR-Cas systems function through 33 
abortive infection (Meeske et al., 2019; Watson et al., 2019). Such mechanistic diversity and prevalence 34 
of abortive infection systems in bacteria underscores the selective advantage this strategy imparts in 35 
the battle against phages. 36 
 37 
However, an important sub-plot in the bacteria-phage conflict is the pervasive existence of so-called 38 
“temperate” or “lysogenic” phages within bacterial genomes. Temperate phages are able to stably exist 39 
within the bacterial chromosome as latent, vertically inherited islands known as a prophages. Crucially, 40 
to find new hosts, prophages must escape from the bacterial genome and return to the lytic life-cycle 41 
(spontaneously, or in response to specific molecular cues). The prophage-state imposes unique 42 
existential pressures, wherein the fitness of the phage is indefinitely tied to that of the bacterium. 43 
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Indirectly enhancing their own fitness, prophages frequently encode “moron” or “accessory” loci that 44 
modulate the biology of host bacteria (Bondy-Denomy and Davidson, 2014; Fortier and Sekulovic, 2013; 45 
Howard-Varona et al., 2017) in a phenomenon likened to altruism (Shub, 1994). Prophage accessory 46 
loci are frequently associated with bacterial pathogenesis, and many notorious bacterial pathogens 47 
depend on prophage-encoded toxins and virulence factors to cause disease (Brüssow et al., 2004; 48 
Fortier and Sekulovic, 2013). However, another trait conferred by prophages that can significantly 49 
increase bacterial fitness, is resistance against bacteriophage attack. Indeed, recent work has shown 50 
that prophage accessory genes may represent an underexplored reservoir of phage-defence systems 51 
(Bondy-Denomy and Davidson, 2014; Dedrick et al., 2017; Snyder, 1995). 52 
Here, we report a novel phage defence system driven by the BstA protein and encoded by prophages 53 
of diverse Gram-negative bacteria. When a bacterium harbours a bstA-encoding prophage, BstA protein 54 
confers effective population-level phage defence through abortive infection. The bstA locus includes an 55 
anti-BstA element, which can suppress the activity of BstA protein to allow the native prophage to 56 
undergo lytic replication. We propose that such elegant molecular systems have evolved to allow 57 
prophages to defend their host cells from predatory phages, without compromising their own potential 58 




The BTP1 prophage-encoded bstA gene mediates phage resistance 63 
 64 
Salmonella enterica subsp. enterica serovar Typhimurium (S. Typhimurium) strain D23580 encodes the 65 
~40 kb prophage BTP1 (Figure 1A) (Owen et al., 2017). An operon within BTP1, the gtr locus 66 
(gtrACBTP1), has been shown to confer resistance against phage P22 due to chemical modification of 67 
the cellular lipopolysaccharide (LPS), which is the receptor for phage P22 (Kintz et al., 2015). 68 
Unsurprisingly therefore, we found deleting the BTP1 prophage from strain D23580 (D23580 DBTP1) 69 
made the strain highly susceptible to infection by phage P22, confirming that resistance to phage P22 70 
is conferred by the BTP1 prophage (Figure 1B). However, inactivation of the gtr locus of prophage BTP1 71 
(D23580 Dtsp-gtrACBTP1) did not restore sensitivity to phage P22 to the level of D23580 DBTP1 (Figure 72 
1B), suggesting a second phage resistance system existed on this prophage. Our previous 73 
transcriptomic study showed that the bstA gene was highly-expressed during lysogeny, and therefore a 74 
candidate for modulation of the biology of the S. Typhimurium cell (Owen et al., 2020). The bstA gene, 75 
encoded downstream of the prophage repressor locus, has been implicated in both virulence, and anti-76 
virulence, of Salmonella isolates, but no functional mechanism has been proposed (Herrero-Fresno et 77 
al., 2014, 2018; Spiegelhauer et al., 2020). We hypothesised that bstA was the second element in the 78 
BTP1 prophage that conferred defence against phage P22. 79 
 80 
Consistent with this hypothesis, removal of the bstA gene from prophage BTP1 (D23580 DbstA), did 81 
dramatically increase susceptibility to phage P22. To confirm that phage resistance was directly  82 
mediated by BstA protein, we introduced two stop codons into the beginning of the bstA coding 83 
sequence by exchanging 4 nucleotides (D23580 bstASTOP) (Figure 1B). D23580 bstASTOP was highly 84 
susceptible to P22 phage, to the same level as D23580 DbstA, demonstrating that BstA protein mediates 85 
defence against phage P22. Simultaneous deletion of the gtr locus and inactivation of the BstA protein 86 
(D23580 Dtsp-gtrACBTP1 bstASTOP) fully recapitulated the susceptibility to phage P22 achieved by deleting 87 
the entire BTP1 prophage (D23580 DBTP1), indicating that resistance to phage P22 is solely mediated 88 
by the bstA and gtr loci in prophage BTP1. We reproduced these findings by replicating phage P22 in 89 
liquid culture, demonstrating that reduction of plaque formation by BstA truly reflected phage replication 90 
suppression (Supplementary Figure 1A).  91 
 92 
To investigate whether the function of the BstA protein depended on other elements on the BTP1 93 
prophage, we constructed an inducible expression system in S. Typhimurium strain LT2. LT2 is the type 94 
strain of S. Typhimurium, and is natively susceptible to many phages, including P22. Expression of the 95 
BstABTP1 protein in S. Typhimurium LT2 from within a neutral position on the chromosome (LT2 tetR-96 
PtetA-bstA) conferred a high degree of resistance to P22 and other phages including ES18 and 9NA 97 
(Figure 1C; Supplementary Figure 1B). Expression of the derivative containing two stop codons at the 98 
beginning of the bstA coding sequence (bstASTOP) did not confer any phage resistance, demonstrating 99 
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again that the effect is mediated by BstA protein (Supplementary Figure 1C). However, BstA did not 100 
mediate resistance against all phages tested: Det7, Felix O1, and notably, phage BTP1 (which encodes 101 
the bstA gene) were unaffected by expression of BstA, both at the level of plaque assay and replication 102 
in liquid culture (Figure 1C; Supplementary Figure 1B). We could not detect any pattern in the 103 
characteristics of phages that were sensitive or insensitive to BstA protein that could relate the 104 
mechanistic action of BstA protein. 105 
106 
Figure 1: The bstA gene of prophage BTP1 confers phage defence 107 
(A) Genomic architecture of prophage BTP1 of S. Typhimurium D23580, according to Owen et al., 2020: the LPS 108 
modification genes gtrACBTP1 (Kintz et al., 2015) and the immunity region carrying bstA (downstream of the cI 109 
repressor gene) are detailed. Bent arrows represent promoters. (B) Removal of prophage BTP1 from strain 110 
D23580 results in enhanced sensitivity to phage P22. Two BTP1 genes confer resistance to P22; gtrAC and bstA. 111 
Plaque assays were performed with phage P22 HT 105/1 int-201 (P22 HT) applied to lawns of S. Typhimurium 112 
D23580 WT or ΔBTP1, ΔbstA, bstASTOP, Δtsp-gtrACBTP1 and Δtsp-gtrACBTP1 bstASTOP mutants (strains JH3877, 113 
SSO-204, SSO-78, JH4287 and SNW431, respectively). The requirement for the inactivation of tsp is describes 114 
in the Methods. The 4 SNPs leading to two nonsense mutations in the bstASTOP strain are indicated. RBS: putative 115 
ribosome binding site. The bstA open reading frame is highlighted in blue. (C) BstA protein confers phage defence 116 
in S. Typhimurium LT2. Phages P22, ES18, P22HT and 9NA are inhibited by BstA. Phages Det7, Felix O1 and 117 
BTP1 are not affected by BstA expression. Plaque assays were carried out with the indicated Salmonella phages 118 
applied to lawns of LT2 tetR-PtetA-bstABTP1 (JH4400) in the absence (BstA-) or the presence of the inducer 119 
anhydrotetracycline (AHT, BstA++). The tetR-PtetA-bstA insertion replacing a part of the STM1553 pseudogene of 120 
strain JH4400 is schematized above: tetR encodes the tetracycline repressor that represses the PtetA promoter in 121 
the absence of AHT induction, “frt” denotes the 84 nt scare sequence of pKD4 and the hairpin represents the 122 
native bstA Rho-independent terminator (term).  123 
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BstA represents a novel family of prophage-encoded phage defence proteins in diverse Gram-124 
negative bacteria 125 
 126 
Having established that BstA functions as a prophage-encoded phage defence system, we sought to 127 
further characterise the occurrence of this protein in bacteria. We found BstA protein homologs in the 128 
genomes of diverse Gram-negative bacteria (Supplementary Table 1) and we compiled a dataset of 72 129 
homologs representative of phylogenetic diversity. The majority (79%) of these BstA homologs co-130 
occurred with phage genes, and therefore were designated as putatively-prophage associated (Figure 131 
2A). No known phage-associated genes were found in the vicinity of 21% (15 of 72) of BstA homologs, 132 
which were considered to be putatively prophage-independent. A small subset of BstA homologs were 133 
plasmid-encoded, and this group included both putatively prophage-associated and -independent 134 
homologs (Figure 2A). Strikingly, in many cases, BstA homologs were located downstream of putative 135 
prophage repressor proteins, mirroring the genetic architecture of BstABTP1 (Figure 2B). The BstA protein 136 
appears to be highly associated with prophages of Gram-negative bacteria. 137 
 138 
Whilst the BstA protein does not exhibit sequence homology to any functionally-characterised proteins, 139 
remote homology detection methods revealed a putative KilA-N domain in the N-terminal region 140 
(residues 32-147 of BstABTP1)) (Figure 2C). Though poorly characterised, the KilA-N domain is found in 141 
proteins from phages and eukaryotic DNA viruses, and contains the helix-turn-helix motif characteristic 142 
of DNA binding proteins (Iyer et al., 2002; Medina et al., 2019). A large screen based on genomic 143 
proximity to known-phage defence systems previously predicted KilA-N domain containing proteins to 144 
play a role in phage defence (Doron et al., 2008). The KilA-N domain derives its name from the kilA 145 
gene product of bacteriophage P1 (lethal when expressed in E. coli) but kilA has no known function in 146 
phage infection biology (Hansen, 1989), and no bacterial KilA-N domain-containing proteins have been 147 
functionally characterised to date. 148 
 149 
Certain residues in the BstA protein are highly conserved amongst homologs from diverse members of 150 
the Alpha-, Beta-, and Gamma- Proteobacteria (Figure 2C; Supplementary Figure 2). A small number 151 
of BstA protein homologs (all found in Cyanobacterial plasmids) only exhibited homology to the N-152 
terminal, putative KilA-N domain. A second small group corresponding to Proteobacteria, Cyanobacteria 153 
and a single Bacteroidetes isolate were only homologous to the C-terminal region of BstA (shown at the 154 
bottom on the alignment in Figure 2C). Such bipartite protein homology suggests that the BstA protein 155 
is composed of two functional domains. Additionally, we observed that the identity of BstA protein 156 
homologs did not obviously correlate with bacterial taxonomy. For example, homologs from enteric 157 
bacteria closely-related to Salmonella (members of the Gammaproteobacteria) sometimes shared less 158 
identity to BstABTP1 than homologs from alpha- and betaproteobacteria, suggesting BstA proteins are 159 
frequently horizontally transferred, perhaps consistent with their association with prophages.  160 
 161 
We selected two diverse BstA homologs from Klebsiella pneumoniae (48.4% amino acid identity to 162 
BstABTP1) and E. coli (41.7% identity) to investigate the phage-resistance function of the larger BstA 163 
protein family (the native genetic context of these homologs is illustrated in Figure 2B, and their identity 164 
to BstABTP1 is highlighted in the alignment in Figure 2C). We engineered inducible expression systems 165 
for the BstA the expression construct we previously validated for BstABTP1 (Figure 3A,B; Figure 1C). 166 
Expression of BstAKp and BstAEc in S. Typhimurium LT2 conferred resistance to Salmonella phages at a 167 
similar level to BstABTP1, despite these homologs only sharing around 40% identity at the amino acid 168 
level (Figure 3A,B; Supplementary Figure 3A). Importantly, BstAKp and BstAEc showed additional activity 169 
against phage BTP1 (which encodes bstABTP1), a property that was not shown by BstABTP1. 170 
 171 
Finally, to investigate the phage-defence function of BstA against well-characterised coliphages, we 172 
expressed BstABTP1 and BstAEc in E. coli. Heterologous expression of BstABTP1 in E. coli strain MG1655 173 
conferred resistance to phage l, f80, P1 and T7, but did not affect phages T4 and T5 (Supplementary 174 
Figure 3B,C). Surprisingly we found BstAEc was slightly less active against coliphages than BstABTP1 175 
(Supplementary Figure 3B,C). We note that replication in liquid culture is a more reliable and 176 
reproducible measure of phage susceptibility than plaque assay, and we frequently observed stronger 177 
resistance phenotypes liquid replication than by plaque assay (Supplementary Figure 3B,C). 178 
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Figure 2: BstA homologs are found in diverse bacterial taxa and are frequently associated with prophages  179 
(A) A dataset of 72 BstA homologs representative of taxonomic diversity were manually curated and analyzed for prophage 180 
association based on the co-occurrence of phage-related Pfam-domains in the 20 kb either side of each homologs (yielding a 181 
total 40 kb window) (Supplementary Table 2). Homologs without co-occurring phage-related protein domains were assigned 182 
as “Putatively prophage-independent”. A further subset of the BstA homologs were encoded on plasmids. The top ten most 183 
commonly co-occurring Pfam domains with prophage-associated and putatively prophage-independent BstA homologs are 184 
shown as bar graphs. (B) Gene maps showing the genetic context of prophage-associated and putatively prophage-185 
independent BstA homologs. Putative prophage repressor genes are highlighted in red. The top three BstA proteins from BTP1 186 
(BstABTP1, blue), K. pneumoniae 52.145 (BstAKp, green) and E. coli NCTC10963 (BstAEc, orange) are studied experimentally 187 
in later stages of this work, and are highlighted. Open reading frames associated with functional annotations are shown as 188 
solid black arrows, and functional gene name or Pfam domains are annotated. (C) An alignment of the 72 BstA protein 189 
homologs to BstABTP1, with colors indicating amino acid conservation. Alignment columns containing gaps relative to the 190 
reference sequence (BstABTP1) have been collapsed and are indicated with blue lines and triangles at the base of the alignment 191 
(an expanded alignment can be found in Supplementary Figure 2). The position of BstAKp and BstAEc within the alignment is 192 
highlighted. The position of the putative KilA-N domain (BstABTP1 residues 32-147) is indicated by a grey box. Heatmaps on the 193 
left of the alignment indicate the prophage and plasmid association of each homolog (lanes 1 & 2), and the taxonomic group 194 
each homolog derives from (lane 3). Prophage association was split into high and low confidence based on gene co-occurrence 195 
criteria (see Methods). 196 
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Figure 3: BstA homologs from Salmonella, E. coli and K. pneumoniae all confer phage defence 197 
Heterologous expression of bstA homologues from (A) E. coli NCTC10963 (bstAEc) and (B) K. pneumoniae Kp52.145 (bstAKp) 198 
in Salmonella strain LT2 confers phage defence at similar levels to bstABTP1, but show additional activity against phage BTP1. 199 
(C) BstABTP1 confers defence against coliphages in E. coli MG1655. Plaque assays were carried out with the indicated phages 200 
applied on mock-induced (BstA-) or AHT-induced (BstA++) lawns of LT2 tetR-PtetA-bstAEc (JH4408), LT2 tetR-PtetA-bstAKp 201 
(JH4404) or MG1655 tetR-PtetA-bstABTP1 (JH4410). The tetR-PtetA-bstA insertions in LT2 or in the glmS-pstS intergenic of 202 
MG1655 are depicted above. 203 
 204 
 205 
We conclude that BstA represents a novel family of phage-resistance proteins associated with 206 
prophages in diverse Gram-negative bacteria. 207 
 208 
BstA mediates effective population-level phage defence through abortive infection 209 
 210 
Phage resistance systems function via diverse functional mechanisms (Hampton et al., 2020; Rostøl 211 
and Marraffini, 2019). We used a microscopy-based approach to understand how BstA mediates phage-212 
resistance. P22 phages were used to infect Salmonella cells with and without native BstABTP1 function, 213 
at high multiplicity of infection (MOI) in order to ensure that most cells were infected. We were surprised 214 
to observe that independent of BstABTP1 function, all cells lysed within the time course of 3 hours (Figure 215 
4A, Supplementary Video 1), and BstABTP1 function did not appear to confer any direct protection from 216 
phage infection. We conducted the same experiment in liquid culture, measuring phage replication and 217 
the fraction of surviving cells post phage infection. In cells possessing functional BstA (D23580 Dtsp-218 
gtrAC), phage P22 Dc2 completely failed to replicate (Figure 4B). In contrast, in the absence of BstA 219 
function (D23580 Dtsp-gtrAC bstASTOP), the phage replicated >100-fold. However, despite preventing 220 
the replication of phage P22, BstABTP1 had no effect on cell survival: independent of BstABTP1 function 221 
only 1-2% of cells survived (Figure 4C). We hypothesised that BstA protein must instead mediate phage 222 
defence at the population level. 223 
 224 
To investigate whether BstA protein mediated population-level phage defence, we conducted a second 225 
microscopy experiment, wherein approximately only 1 in every 1000 cells was infected with phage P22. 226 
Unlike during liquid culture, in our microscopy setup cells were immobilised on agarose pads, which 227 
restricts the movement of phage particles to local diffusion. Using this setup, we tracked the spread of 228 
infection as primary infected cells lysed and produced secondary infections. To facilitate tracking of 229 
phage replication, we used a reporter phage engineered to encode the red fluorescent protein mCherry 230 
within the early lytic operon (P22Dc2 p-mCherry), so that fluorescence signal indicated phage replication 231 
(Figure 4D).  232 
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Figure 4: BstA mediates population-level phage defence through abortive infection 233 
BstA protein does not protect individual cells from phage infection. (A) Cells natively expressing BstA [D23580 Δtsp-gtrAC, 234 
JH4287] or possessing a mutated BstA locus [D23580 Δtsp-gtrAC bstASTOP, SNW431] were infected with the obligately virulent 235 
P22-derivate phage, P22Δc2, at an MOI of 5 to increase the likelihood of infecting all cells. Infected cells were imaged on 236 
agarose pads and the images represent a time series. Regardless of BstA function, almost all cells were observed to lyse 237 
(indicated by loss of defined cell shape and phase contrast). Videos of the time series are presented in Supplementary Video 238 
1. (B) A phage replication assay showed that P22Δc2 phage failed to replicate after three hours growth on the BstA+ strain 239 
[D23580 Δtsp-gtrAC], but replicated ~136-fold when BstA was inactivated [D23580 Δtsp-gtrAC bstASTOP]. (C) Survival assay 240 
of the same strains after infection by phage P22Δc2, at an MOI of 5. Consistent with the microscopy data in (A), BstA function 241 
did not affect cell survival from phage infection. D23580 ΔΦ [P22] (SSO-128), a phage P22 lysogen (and therefore natively 242 
resistant), was used as a negative control. (D) A fluorescent reporter module for phage replication was added to P22Δc2 243 
(P22Δc2 p-mcherry) so that phage replication yielded red fluorescence (mcherry was inserted into the lytic genes of the phage). 244 
A similar experiment to (A) was conducted, but P22Δc2 p-mcherry infected cells were mixed 1:1000 with uninfected cells. In 245 
the BstA+ cells, primary infected cells lysed, but did not stimulate secondary infections of neighbouring cells, and eventually 246 
formed a confluent lawn. In BstA- cells, primary lysis events caused secondary infections (neighbouring cells showing red 247 
fluorescence and subsequent lysis) causing an epidemic of phage infection reminiscent of plaque formation. Cartoons 248 
schematise the outcomes of these experiments in the two strain backgrounds. Videos of the time series are presented in 249 
Supplementary Video 2. 250 
 251 
In the population lacking functional BstABTP1 (D23580 Dtsp-gtrAC bstASTOP), primary infected cells lysed 252 
after around 30 minutes (Figure 4D, Supplementary Video 2). Subsequently, the red fluorescence signal 253 
was observed in neighbouring cells revealing secondary infection, followed by cell lysis, a cycle which 254 
repeated until all cells in the radius of the primary infected cell had lysed, reminiscent of plaque formation 255 
(Figure 4C). The impact of the epidemic of phage infection upon bacterial cells lacking BstABTP1 can be 256 
seen clearly in Supplementary Video 2. 257 
 258 
In contrast, in the population with native BstA activity (D23580 Dtsp-gtrAC) no fluorescence signal or 259 
lysis was observed in neighbouring cells following the lysis of the primary infected cells. Instead, 260 
neighbouring cells continued to grow, eventually forming a confluent lawn (Figure 4D, Supplementary 261 
Video 2). The lack of subsequent rounds of secondary infection after the primary cell lysis events 262 
indicates that viable phage were not released upon cell lysis. Furthermore,  263 
 264 
Taken together, these experiments demonstrate that BstA protein inhibits successful phage replication, 265 
but does not prevent the death of the infected cell. BstA therefore provides phage defence at the 266 
population-level and prevents the spread of phage epidemics. We propose that BstA is a novel abortive 267 
infection system: a population-level phage defence system that inhibits phage infection at the cost of 268 
cell viability. 269 
  270 
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Figure 5: BstA protein responds dynamically to phage infection and colocalises with phage DNA 271 
(A) A translational fusion of BstA protein to sfGFP protein (D23580 bstA-sfgfp, SNW403) was constructed to track the location 272 
of BstA protein inside cells. In the absence of phage infection, GFP signal is diffuse within the cell cytoplasm, suggesting no 273 
specific sub-cellular localisation. (B) A microfluidic growth chamber was used to observe the behaviour of BstA protein during 274 
phage infection, capturing images every 1.5 minutes. A time series of representative fields are presented as composite images 275 
(phage contrast, green and red fluorescence are overlaid). Cells were first grown for a period in the chamber (immobilised by 276 
the angle of the chamber ceiling) with constant flow of M9 Glu+ media (Methods). Fluorescently labelled phages P22 HT or 277 
9NA (stained with SYTOX Orange resuspended in M9 Glu+ media , Methods) were then added to the cells, and can be seen 278 
adsorping to cells as red fluorescent puncta (red arrows). For purposes of comparison, timestamps are synchronised to the 279 
point at which phage are first observed. Typically around 20 minutes after initial observation of phage infection, BstA proteins 280 
formed discrete and dynamic foci within the cells (green arrows). Cells then proceeded to lyse (white arrows), consistent with 281 
previous microscopy data in Figure 4. Videos of the time series are presented in Supplementary Video 3. (C) A microfluidic 282 
growth chamber was used to co-localise BstA protein and the DNA of infection phage. SVO251 cells (expressing the BstA-283 
sfGFP fusion and a ParB-mCherry fusion protein) were grown for a period of 15 minutes before P22 Δpid::parS-aph phages 284 
were flowed across the cells. The ParB-mCherry fusion protein oligomerises at the parS site on the infecting phage DNA, so 285 
that mCherry foci indicate the subcellular location of phage DNA (red arrows). For the purposed of comparison, the time stamp 286 
was set to zero at the first observation of mCherry foci (i.e. the earliest detectable event of phage infection). BstA foci formed 287 
directly after appearance of mCherry foci (green arrows), and merging of the images (composite) shows that the foci are 288 
overlapping, indicating that BstA foci correspond to infecting phage DNA. Cells proceeded to lyse (white arrows). Videos of the 289 
time series are presented in Supplementary Video 4. 290 
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BstA protein responds dynamically to phage infection and co-localises with phage DNA 291 
 292 
To explore the molecular activity of BstA during phage infection, we constructed a translational fusion 293 
of the BstABTP1 protein to superfolder green fluorescent protein (sfGFP), confirming that the translational 294 
fusion did not compromise the function of the BstA protein (Supplementary Figure S4). We used time-295 
lapse fluorescence microscopy to observe the dynamics of BstA protein inside individual cells during 296 
infection with two phages P22 and 9NA. In the absence of phage infection, BstA protein was distributed 297 
diffusely within the cytoplasm of the cells, suggesting no particular sub-cellular localisation (Figure 5A, 298 
Supplementary Video 3). However, approximately 20 minutes after infection with phages P22 and 9NA, 299 
we consistently observed BstA protein aggregating into discrete foci towards the centre of infected cells 300 
(Figure 5B, Supplementary Video 3). Cell lysis occurred approximately 40 minutes after the formation 301 
of BstA foci. 302 
 303 
We speculated that the dynamic establishment of foci by BstA in response to phage infection was likely 304 
to reflect the mechanistic activity of the BstA protein. We noticed that the dynamics of the foci formed 305 
by BstA proteins during phage infection were reminiscent of live-cell fluorescence microscopy studies 306 
of phage replisomes (Cenens et al., 2013; Trinh et al., 2017). We therefore speculated that the focus of 307 
BstA protein in phage infected cells might correspond to the replicating phage DNA. To test this 308 
hypothesis, we used a ParB-parS system to track the sub-cellular localisation of phage DNA relative to 309 
BstA protein. We inserted a parS site into the P22 phage chromosome, and expressed a ParB-mCherry 310 
fusion protein inside cells already expressing BstA-sfGFP. ParB protein oligomerises onto DNA at parS 311 
sites, and therefore parS-tagged DNA is indicated by ParB-mCherry foci. We conducted a microfluidic 312 
infection experiment to co-locate BstA foci and infecting P22 phage DNA, and we observed that the 313 
position of ParB-mCherry foci (corresponding to phage P22 DNA) clearly overlapped with foci formed 314 
by BstA-sfGFP (Figure 5C, Supplementary Video 4). The microscopy data suggest that BstA protein 315 
interacts with the replicating DNA of infecting phages. 316 
 317 
Together the data are consistent with a model where BstA proteins are titrated to sites of phage 318 
replication inside infected cells, to suppress the successful multiplication of the phage. 319 
 320 
BstA phage resistance systems contain anti-BstA elements (aba) that suppress the activity of 321 
BstA 322 
 323 
When characterising the sensitivity of different phages to the activity of BstABTP1 using our heterologous 324 
expression system (Figure 1C), we observed that BTP1 phage, (which itself encodes the bstABTP1 gene) 325 
was not affected by expression of BstABTP1 (schematised in Figure 6A). We hypothesized that BTP1 326 
carries an anti-BstA determinant: a self-immunity factor that allows phage BTP1 to replicate without 327 
being targeted by its own abortive infection protein. Consistent with this hypothesis, phage BTP1 328 
became sensitive to BstABTP1 expression when the bstA coding sequence was deleted (BTP1 DbstA). 329 
(Figure 6B). The self-immunity function of the bstA locus was not affected by the introduction of the 330 
double stop codon mutation into the beginning of the coding sequence (as described in Figure 1B), 331 
indicating that self-immunity is not mediated by the BstA protein itself, but by an alternative genetic 332 
element encoded within the bstA locus (Figure 6B). Here, and for the duration of this report, we define 333 
the bstA “locus” as the region including the bstA coding sequence and the 5’ upstream sequence. 334 
 335 
To identify the precise genetic basis of BstA self-immunity, we constructed a library of BTP1 mutant 336 
phages, carrying truncations of different lengths from the 3’ end of the bstA locus (Supplementary Figure 337 
5A) and screened these phages for their ability to replicate in the presence of BstABTP1 expression. Self-338 
immunity was preserved in all the mutant phages (i.e. insensitivity to BstABTP1 expression) except the 339 
mutant with the largest bstA truncation (BTP1 bstA∆24), in which just the first 24 bp of the bstA reading 340 
frame were intact (Supplementary Figure 5A). A similar truncation mutant containing just the first 34 bp 341 
of bstA (BTP1 bstA∆34) retained immunity to BstA, indicating that the anti-BstA determinant was encoded 342 
within the upstream region and first 34 bp of the bstA gene. Consistently, the transfer of bstA∆34 (the first 343 
34 bp of bstA, including the upstream sequence) to phage P22 (P22 bstA∆34I), conferred BstA immunity 344 
(Supplementary Figure 5B). To identify the minimal sequence required for BstA self-immunity, we 345 
constructed further P22 bstA∆34I-derived phages, successively truncating the transferred sequence from 346 
the 5’ end (P22 bstA∆34I - P22 bstA∆34V, Supplementary Figure 5B). We discovered that a 63 bp sequence 347 
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(GCCCGCCACACTTTAACAAGGAAAATCAAATGGTTAATCAGATAAGGTCCATATCACCCCGCC) 348 
spanning 29 bp of the upstream region and the first 34 bp of bstA (start codon underlined) was necessary 349 
and sufficient to confer the self-immunity (Figure 6C). We designated this 63 bp element ‘aba’, for anti-350 
BstA. Supplying the 63 bp aba sequence on the high-copy number pUC18 plasmid (pUC18-aba) 351 
rescued P22 phage replication in the presence of BstA protein, demonstrating that the self-immunity 352 
function of aba functions in trans (Supplementary Figure 6A).  353 
 354 
The aba element is DNA-based 355 
 356 
In the native BTP1 prophage, the aba sequence overlaps the start of the bstA gene, preventing the 357 
mutational disruption of the aba element without modifying the BstA protein sequence. We therefore 358 
used the simple multi-copy plasmid trans-complementation system (wherein the BstA protein and the 359 
aba sequence are independently encoded) to further probe the function of the aba sequence 360 
(Supplementary Figures 6A). A notable feature of the 63 bp aba sequence is the presence of a direct 361 
“CCCGCC” repeat at the terminal ends, which we hypothesised might be functionally important. Single 362 
nucleotide exchange of the CCCGCCàCCCTCC in the first (abamut1) and second (abamut2) repeat 363 
abolished the self-immunity function of the aba element on the phage and in trans (Supplementary 364 
Figure 6B) showing that the aba terminal direct repeats are important for the aba-BstA interaction. 365 
 366 
The aba plasmid trans-complementation system additionally allowed us to interrogate the genetic nature 367 
of the aba element, which we hypothesised could be either DNA, RNA transcript or peptide-based. 368 
Though three short open reading frames exist within the aba sequence, (Supplementary Figure 6C), 369 
non-synonymous mutations of the reading frames did not ablate aba function, suggesting the aba-driven 370 
immunity is not mediated by a short peptide. Secondly, we tested whether transcription of aba was 371 
necessary for immunity. The aba sequence was cloned in either orientation into the Salmonella 372 
chromosome, downstream of the arabinose-inducible PBAD promoter (D23580 ΔΦ tetR-bstABTP1 PBAD-373 
aba; Supplementary Figure 6D) to produce high levels of aba RNA transcripts. High-level transcription 374 
of aba RNA did not restore P22 or 9NA plaque formation in the presence of BstA protein, suggesting 375 
transcription of aba is not required for anti-BstA activity. However, this experiment also demonstrated 376 
that supplying aba as a single copy on the chromosome also did not confer self-immunity 377 
(Supplementary Figure 6D), suggesting that aba can only suppress BstA protein when it is encoded on 378 
high-copy replicative elements. Further mutational disruption of the aba sequence revealed that the self-379 
immunity function was not robust to mutation at multiple sites in the 63 bp sequence (Supplementary 380 
Figure 6E). Collectively, our data suggest that aba-driven suppression of BstA is neither peptide or 381 
transcript mediated, and instead support a model where BstA suppression is mediated by aba DNA in 382 
trans, perhaps by a copy-number dependent mechanism. 383 
 384 
The aba element prevents the bstA-encoding prophage from aborting its own lytic replication 385 
 386 
A unique feature of the BstA system, unusual amongst the majority of mechanistically-characterised 387 
abortive infection systems, is its frequent occurrence on prophages (latent forms of active phages) 388 
(Figure 2A). Prophages must be able to switch to lytic replication, or else the prophage-state becomes 389 
an evolutionary dead-end for the phage. It follows therefore, that prophages must be obligately immune 390 
to any self-encoded phage-defence systems. Despite this intuitive assumption, self-immunity functions 391 
in prophage-encoded phage defence systems have not been previously identified. 392 
 393 
We hypothesised that the primary biological role of the aba element is to allow the endogenous bstA-394 
encoding phage to escape BstA-mediated inhibition upon induction from the prophage-state. To test 395 
this, we measured the level of induction of prophage P22 in the presence of heterologously expressed 396 
BstABTP1 protein (Figure 6D). In the absence of BstABTP1, the P22 prophage generated a titer of ~4x109 397 
PFU/mL after 5 hours growth with inducing agent (mitomycin C, MitC). However, with BstABTP1 398 
expression, the MitC-induced titer of P22 dropped >300-fold to ~1x107 PFU/mL, consistent with BstA-399 
mediated inhibition of P22 phage replication. Transfer of the aba sequence to prophage P22 (P22 aba) 400 
significantly increased the induced titer in the presence of BstABTP1 to ~3x109, restoring it to the level 401 
seen in the absence of BstA, showing that the aba element rescues phage replication via suppression 402 
of BstA. 403 
 404 
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Consistent with our hypothesis, we found the abamut1 mutation (exchange of a single functionally 405 
important nucleotide in the terminal direct repeat) reduced the MitC-induced titer of phage BTP1 ~14-406 
fold in the presence of BstA. This reduction was rescued by supplying the functional aba sequence in 407 
trans on the pUC18 plasmid (Figure 6E), confirming that the abamut1 mutation ablates the function of the 408 
aba element. 409 
 410 
These intricate experiments demonstrate that an aba element is required for the bstA-encoding 411 
prophage to switch from lysogenic to lytic replication. In the absence of aba, the bstA-encoding prophage 412 
suffers replication inhibition by its own BstA protein (self-targeting), presumably by the same abortive 413 
infection mechanism that inhibits exogenous phage infection. 414 
 415 
Possession of a functional aba element, which specifically suppresses BstA activity during prophage 416 
replication (perhaps via a copy-number dependent mechanism), is required to allow the prophage to 417 
protect its host from phage infection during lysogeny, whilst permitting its own lytic replication upon 418 
induction. 419 
Figure 6: BstA systems include cognate self-immunity elements, aba, which are required for successful prophage 420 
induction 421 
(A) Cartoon summarising the data from Figure 1C. The BTP1 phage, which encodes the bstA locus, is not affected by 422 
heterologous expression of BstABTP1. (B) Schematic of the BTP1-derived phages used. (C) Schematic of the BTP1-derived 423 
phages used. In all cases, introduced sequences (bstA homologs or fragments) were inserted downstream of the c2 repressor 424 
gene of P22 and are linked to the frt sequence. Hairpins represent rho-independent terminators. Insensitivity of the BTP1 phage 425 
to BstABTP1 is dependent on the bstA locus on the phage chromosome. However, only the first 34 bp of the bstA locus are 426 
required. The aba sequence in P22 and BTP1 counteracts the BstA-driven phage resistance and the GàT mutation (abamu1) 427 
suppresses the anti-bstA interference. Plaque assays presented in panels B & C were carried out with the indicated phages, 428 
applied on mock-induced (BstA-) or AHT-induced (BstA++) lawns of the indicated strain (strains JH4400, JH4404 and JH4408 429 
for panel B, SNW576 for panel C). (D) BstA represses P22 prophage induction in the absence of aba. P22 induction was 430 
measured in D23580 ΔΦ tetR-PtetA-bstABTP1 lysogenized with prophages P22 WT or P22 aba (strain SNW583 and SNW585, 431 
respectively). Induction was measured 4 hours post AHT-induction (BstA++) or mock-induction (BstA-). (E) Endogenous bstA 432 
of BTP1 represses prophage induction in the presence of the abamut1 mutation. Prophage spontaneous induction was measured 433 
in strain D23580 ΔΦ ΔTn21 (ApS) lysogenized with BTP1 WT (abaWT) or BTP1 abamut1 (strain SNW597 and SNW598, 434 
respectively). Lysogens were transformed with pUC18 (vector) or pUC18-aba (pNAW203, +aba) and prophage induction was 435 
measured 5 hours post induction with Mitomycin C. Data E & F are presented as the mean of biological triplicates ± SD. Groups 436 
were compared using unpaired two-tailed Student t-test and P values and significance are indicated by *,**,***,**** or ns (not 437 
significant). (F) Each bstA locus encodes a homolog-specific anti-bstA element (aba) that suppresses BstA-mediated phage 438 
defence. Transfer of each bstA locus to phage P22 confers immunity against the cognate BstA protein only.  439 
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Distinct BstA proteins are associated with cognate aba elements 440 
 441 
Finally, we determined whether the aba sequence from bstABTP1 could suppress the activity of the BstA 442 
proteins of other bacteria. We challenged the P22 bstABTP1 phage (immune to expression of BstABTP1 443 
due to the presence of aba) against expression of BstAEc or BstAKp. The bstABTP1 locus did not protect 444 
P22 from the heterologous BstA proteins, indicating that each BstA protein has a cognate aba element 445 
(Figure 6F). To further test this hypothesis, we engineered P22 phages to encode either bstAEc or bstAKp 446 
(including the respective upstream sequence). Consistent with a cognate BstA-aba interaction, P22 447 
bstAEc became specifically immune to expression of BstAEc; and P22 bstAKp gained specific immunity to 448 
BstAKp expression (Figure 6F). Each bstA locus therefore encodes highly-specific self-immunity. We 449 
conclude that though BstA proteins are broadly functionally interchangeable in terms of phage-defence 450 
activity, each bstA locus contains a cognate aba element, inactive against heterologous BstA proteins. 451 
The specificity of the aba self-immunity element means that heterologous bstA-encoding phages cannot 452 
bypass BstA-mediated abortive infection, and aba-mediated suppression of BstA is exclusive to the 453 
induced prophage. 454 
 455 
BstA protein inhibits the replication of phage DNA 456 
 457 
Sequence-based analysis of BstA protein homologs suggested that the N-terminal domain may bind 458 
DNA (Figure 2C), and fluorescence microscopy showed BstA protein interacting with phage DNA. The 459 
replication of DNA is a crucial for phage morphogenesis, as new copies of the phage chromosome are 460 
required for packaging into capsids. To test whether BstA protein inhibits phage DNA replication in a 461 
manner that can be suppressed by aba, we conducted Southern blot experiments to monitor levels of 462 
phage DNA during infection. Using our prophage-negative, inducible BstA-expression strain (D23580 463 
∆Φ tetR-PtetA-bstABTP1), we first tested the replication of the BstA-sensitive virulent phage, 9NA. In the 464 
absence of BstA expression, the level of phage 9NA DNA gradually increased over a 50 minute infection 465 
time course, indicating successful phage replication (Figure 7A). No accumulation of phage 9NA DNA 466 
was observed in the presence of BstABTP1, suggesting that BstA protein strongly inhibited the replication 467 
of phage DNA. 468 
 469 
Consistent with the self-immunity function of aba, BTP1 phage DNA replication was not affected by the 470 
expression of BstABTP1, unless the aba element was non-functional (BTP1 abamut1) (Figure 7B). Likewise, 471 
successful replication of phage P22 DNA in the presence of BstABTP1 only occurred when the phage 472 
possessed a functional aba element (Figure 6B). 473 
 474 
To confirm that BstA protein inhibits DNA replication, we constructed small phage-derived plasmids 475 
(‘phagemids’) based on the phage P22 replication module (Figure 7C). P22 phagemid derivatives that 476 
included the functional 63 bp aba sequence (pP22-aba), or the non-functional abamut1 sequence (pP22-477 
abamut1) were made. 478 
 479 
The P22 phagemids were transformed into Salmonella cells in the presence or absence of BstABTP1 480 
protein expression. In the absence of BstA, the stable replication of all three P22 phagemids in 481 
Salmonella cells generated >106 transformants /ng phagemid. However, expression of BstABTP1 reduced 482 
the transformation efficiency of pP22 (lacking the aba sequence) to around 101 transformants /ng. 483 
Addition of the aba sequence to the phagemid (pP22-aba) restored the transformation efficiency of the 484 
phagemid in the presence of BstA to BstA-negative levels.  485 
 486 
We conclude that phage DNA replication is strongly suppressed by BstA, but replication can be rescued 487 
by the aba element, presumably by inhibition of BstA protein. As replicated phage DNA is an essential 488 
substrate for packaging into phage capsids, the inhibition of DNA replication is likely to prevent the 489 
production of infectious progeny phages. We propose that BstA blocks phage replication by inhibiting 490 
DNA replication, a process that can be suppressed by the native prophage with the aba self-immunity 491 
element.  492 
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Figure 7: BstA protein inhibits phage DNA replication in the absence of aba 493 
DNA replication of 9NA phage (A), BTP1 and P22-derived phages (B) in the absence or presence of 494 
BstA expression. Phage DNA was detected by Southern blotting with total DNA extracted from mock-495 
induced (BstA-) or AHT-induced (BstA++) host strain D23580 ΔΦ tetR-PtetA-bstABTP1 (SNW576), infected 496 
by the indicated phage at M.O.I.=5. Before the transfer procedures, total stained DNA was visualized 497 
from gels under UV light and the resulting pictures served as loading control. Min PI = minutes post 498 
infection. Non-infected SNW576 DNA was used as negative control to check the DNA probe specificity. 499 
(C) aba dramatically increases the transformation efficiency of P22 derived phagemids in BstA 500 
expressing Salmonella. The KmR phagemids pP22 (pNAW229), pP22-aba (pNAW230) and P22-abamut1 501 
(pNAW231) are schematized and the efficiency of transformation for each phagemid was measured in 502 
Mock- or AHT-induced competent bacteria of strain D23580 ΔΦ tetR-PtetA-bstABTP1 (SNW576). Data are 503 




Prophages (latent phages residing within the genomes of bacteria) frequently encode accessory genes 508 
that bestow beneficial functions on their host bacteria (Bondy-Denomy and Davidson, 2014). A function 509 
that can significantly increase bacterial fitness in many environments is phage resistance, and 510 
prophages may represent a large reservoir of uncharacterised phage defence systems (Dedrick et al., 511 
2017; Snyder, 1995).  512 
 513 
Here, we have discovered a novel family of prophage-encoded abortive infection proteins (BstA) which 514 
efficiently defend bacterial populations from phage epidemics. BstA protein is constitutively expressed 515 
inside cells that carry the prophage, and provides effective population-level phage defence through 516 
abortive infection, inhibiting phage replication at the cost of the viability of individual infected cells. 517 
Possession of such innate phage defence systems by active prophages imposes an obvious challenge: 518 
the prophage must avoid self-targeting by its own defence system when switching to lytic replication. 519 
 520 
We realised that the native prophage which encodes BstA required a mechanism to counteract the 521 
protein upon induction from the prophage-state, to avoid aborting its own lytic replication. The BstA 522 
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system solves this problem with the aba element (anti-BstA), a co-encoded short DNA sequence that 523 
specifically suppresses the activity of BstA protein upon prophage induction, giving the induced 524 
prophage self-immunity to BstA. Theoretically, such a system might leave BstA-expressing cells 525 
vulnerable to infection by heterologous BstA-encoding phages, which could use their own aba element 526 
to bypass native BstA. This problem is avoided by each BstA protein being suppressed only by its 527 
cognate aba element, ensuring that BstA supression is specific to the native BstA-encoding prophage. 528 
 529 
Despite having been studied for over 60 years, abortive infection systems remain mysterious, and very 530 
few have been characterised more deeply than the level of broad functional mechanism (Labrie et al., 531 
2010). Here, we present a complete high-level picture of the BstA phage defence system, and the 532 
corresponding anti-BstA aba element. We are left with two major questions regarding the BstA protein. 533 
Firstly, what are the phage determinants for BstA sensitivity? Though BstA was active against 534 
approximately 50% of the phages tested, we did not to detect similarities between BstA-targeted and 535 
non-targeted phages that could reflect the molecular determinants of sensitivity. It remains possible that 536 
rather than responding to a physical phage stimulus, such as phage DNA or protein, BstA protein 537 
responds to a cellular stimulus produced by the infection of specific types of phages. 538 
 539 
Secondly, what is the precise molecular mechanism by which BstA protein inhibits phage DNA 540 
replication? Our data show that phage DNA does not replicate in the presence of BstA. The existence 541 
of a putative DNA-binding domain in BstA proteins, and microscopic observation of BstA co-localisation 542 
with phage DNA makes it tempting to speculate that BstA interacts physically with phage DNA, for 543 
example by occlusion of a replication initiation site. In the well-characterised phages P22 and Lambda, 544 
DNA replication initially occurs bi-directionally from the origin of replication, generating circular q-form 545 
intermediates (Weigel and Seitz, 2006). These circular forms act as templates for subsequent rolling-546 
circle replication, generating the long concatemeric phage chromosomes needed as the substrate for 547 
the packaging machinery of most tailed phages (Fujisawa and Morita, 1997). We speculate that the 548 
timing of BstA focus formation, approximately 20 minutes after phage infection, is consistent with the 549 
formation of circular q-form phage DNA. It is possible that BstA specifically inhibits the switch to rolling 550 
circle DNA replication, thereby limiting the availability of linear phage chromosomes for packaging into 551 
progeny phage capsids. Such a mechanism has been proposed to explain how phage satellites are able 552 
to block replication of the ICP1 phage in Vibrio cholerae (Barth et al., 2020). Furthermore, numerous 553 
Abi systems in Lactococcus have been proposed to interfere with phage DNA replicative functions 554 
(Chopin et al., 2005), though the molecular mechanisms have not been characterised. 555 
 556 
Alongside the mechanistic details of the BstA protein that have yet to be established, little is known 557 
about the interaction of BstA with the aba element. Our data show that aba interacts with BstA in DNA 558 
form, but the mechanism by which aba DNA suppresses BstA protein is unclear. Our data indicate that 559 
multiple copies of the aba element can suppress BstA protein activity in trans, which could explain why 560 
aba function is specific to prophage induction (when prophage DNA is replicated to a high copy number). 561 
Further study of the BstA-aba system is required to resolve the precise molecular mechanisms by which 562 
BstA-encoding prophages, such as BTP1, achieve self-immunity. 563 
 564 
We consistently observed that phage-infected cells underwent cell lysis independent of the activity of 565 
BstA protein. However we cannot be certain whether BstA protein causes cell lysis actively or passively. 566 
Abi systems have frequently been termed “altruistic suicide” systems, which mediate “programmed cell 567 
death” in response to phage infection (Abedon, 2012; Shub, 1994). Whilst perhaps a useful conceptual 568 
analogy for the strictly population-level effect of Abi systems, this narrative implies that Abi systems 569 
actively cause cell death. Though this is likely to sometimes be the case, such as in the CBASS system 570 
(Cohen et al., 2019) or toxin anti-toxin based systems (Fineran et al., 2009), Abi can also be achieved 571 
by simple disruption of the phage replication pathway. Because phage lysis is generally a temporally 572 
programmed event that occurs independently of successful virion morphogenesis (Cahill & Young, 573 
2018), phage-mediated cell lysis can occur in the absence of virion assembly. For example many 574 
Lactococcus Abi target aspects of phage replication, such as AbiZ, which may interact with phage holin 575 
proteins, to stimulate premature cell-lysis before virion assembly is completed (Durmaz and 576 
Klaenhammer, 2007).  577 
 578 
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It is possible that BstA protein simply inhibits infectious phage particle formation, for example by 579 
precluding the formation of concatemeric DNA for packaging, whilst allowing the phage lysis pathway 580 
to proceed unperturbed. As we did not observe a difference in the timing of cell lysis for phage infected 581 
cells in the presence or absence of BstA during microscopy studies, we prefer a model where the BstA 582 
protein allows the phage lytic pathway to proceed as normal to cell lysis, except that infectious progeny 583 
phage particles are not released. 584 
 585 
An intriguing feature of the BstA phage defence system is its tight association with prophages, and 586 
specifically, with the prophage repressor locus. Though we found homologs in diverse Gram-negative 587 
bacteria, the genetic architecture of the bstA locus (i.e. lying downstream of, and presumably sharing 588 
the promoter of the prophage repressor) was strikingly conserved. The region between the repressor 589 
(cI) and n gene of lambdoid phages has previously been identified as a hotspot of mosaic diversity 590 
(Degnan et al., 2007). In fact, the corresponding site in phage Lambda harbours the rexAB genes, 591 
perhaps the most widely studied prophage-encoded abortive infection system (Snyder, 1995). Despite 592 
>60 years of research, the molecular mechanisms governing RexAB activity are poorly understood. 593 
RexB is reported to be an ion channel, which triggers loss of cell membrane potential upon activation 594 
by the intracellular sensor RexA (Labrie et al., 2010; Snyder, 1995). Whilst not mechanistically 595 
comparable to BstA, perhaps the shared synteny of the BstA and RexAB abortive infection systems 596 
points to a functional significance of this genomic region, as the cI repressor gene is one of the most 597 
highly transcribed prophage promoters during lysogeny.  598 
 599 
Though somewhat functionally analogous to toxin-antitoxin systems, to our knowledge no other example 600 
of self-immunity mechanisms have been described within prophage-encoded abortive infection 601 
systems. However there is some evidence supporting the widespread existence of such mechanisms. 602 
For example, it was observed that the activity of Lambda RexB protein can be suppressed by 603 
overexpression of the rexB gene relative to rexA. It was speculated, but not shown experimentally, that 604 
high levels of RexB might allow phage Lambda to replicate lytically in the presence of RexAB (Parma 605 
et al., 1992) i.e. giving the Lambda prophage self-immunity against its own Abi proteins. Our discovery 606 
of the BstA and the aba element strongly supports this hypothesis. 607 
 608 
The discovery of the BstA-aba system opens unexplored avenues of research into the mechanisms 609 
used by prophages to suppress their own phage-defence activities. We anticipate that similar strategies 610 
may be widespread and commonplace, perhaps existing within characterised prophage-encoded phage 611 
defence systems. Given the huge mosaic diversity of temperate phages, and high prevalence of 612 
uncharacterised accessory genes, the reservoir of prophage-encoded phage defence and self-immunity 613 
systems is likely vast and largely unexplored.  614 
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Methods 615 
 616 
RESOURCE AVAILABILITY 617 
Further information and requests for bacterial and bacteriophage strains should be addressed to the 618 
Lead Contact. 619 
 620 
EXPERIMENTAL MODEL AND SUBJECT DETAILS 621 
Bacteria and bacteriophages 622 
The full list of bacterial strains used and constructed is available in Supplementary Table 2. All the 623 
Salmonella strains were derived from the African S. Typhimurium strain D23580 (GenBank: 624 
FN424405.1) (Kingsley et al., 2009) or the model S. Typhimurium strain LT2 (GenBank: 625 
AE006468.2)(McClelland et al., 2001; Zinder and Lederberg, 1952). All the Escherichia coli strains 626 
constructed were derived from E. coli strain K-12 substrain MG1655 (GenBank: NC_000913.3) (Riley 627 
et al., 2006). The bstA homologs were cloned from E. coli NCTC10963 (GenBank: 628 
NZ_CAADJH010000002.1) or from Klebsiella pneumoniae Kp52.145 (GenBank: FO834906.1) (Bialek-629 
Davenet et al., 2014). Bacteriophages (phages), including the temperate phages P22 (GenBank: 630 
NC_002371.2) (Pedulla et al., 2003) and BTP1 (GenBank; NC_042346.1) (Owen et al., 2017) and their 631 
derivatives, are described in Supplementary Table 2. The genomic coordinates and gene identifiers 632 
indicated below refer to the GenBank accession numbers mentioned above. 633 
 634 
METHOD DETAILS 635 
Growth conditions and transformation 636 
All suppliers of chemical and reagents are specified in the Key Resources Table. Unless stated 637 
otherwise, bacteria were grown at 37°C in autoclaved Lennox Broth (LB: 10 g/L Bacto Tryptone, 5 g/L 638 
Bacto Yeast Extract, 5 g/L NaCl) with aeration (shaking 220 rpm) or on LB agar plates, solidified with 639 
1.5% Agar. The salt-free LBO media contained 10 g/L Bacto Tryptone, 5 g/L Bacto Yeast Extract. Pre-640 
cultures were inoculated with isolated colonies from agar plates and grown to stationary phase (for at 641 
least 6 hours) in 5 mL LB in 30 mL universal glass tubes or in 50 mL plastic tubes (Greiner). 642 
 643 
Cultures were typically prepared by diluting the pre-cultures [1:100] or [1:1000] in LB, and bacteria were 644 
grown in conical flasks containing 10% of their capacity of medium (i.e. 25 mL LB in a 250 mL conical 645 
flask) with aeration. For fluorescent microscopy experiments, bacteria were grown in M9 minimal 646 
medium (Sambrook and Russell, 2001) supplemented with 0.4% glucose and 0.1% Bacto Casamino 647 
Acids Technical (M9 Glu+). 648 
  649 
When required, antibiotics were added to the media: 50 µg/mL kanamycin monosulfate (Km), 100 µg/mL 650 
Ampicillin sodium (Ap), 25 µg/mL tetracycline hydrochloride (Tc), 20 µg/mL gentamicin sulfate (Gm), 20 651 
µg/mL chloramphenicol (Cm). Bacteria carrying inducible constructs with genes under the control of the 652 
PBAD or Pm promoters were induced by adding 0.2 % (w/v) L-(+)-arabinose or 1 mM m-toluate, 653 
respectively. For the strains carrying tetR-PtetA modules, PtetA induction was triggered by adding 500 654 
ng/mL of anhydrotetracycline hydrochloride (AHT, stock solubilized in methanol). For these constructs, 655 
the same volume of methanol was added to the non-induced cultures (mock treatment). Chemically-656 
competent E. coli were prepared with RbCl-based solutions and were transformed by heat shock (Green 657 
and Rogers, 2014). 658 
 659 
For the preparation of electro-competent cells, bacteria were grown in the salt-free medium LBO to an 660 
Optical Density at 600 nm (OD600) of 0.4-0.5. The bacteria were washed twice with cold sterile Milli-Q 661 
water (same volume as the culture volume) and were concentrated 100 times in cold 10% glycerol, prior 662 
to storage at -80°C. When ultra-competent Salmonella cells were required, the bacteria were grown in 663 
LBO at 45°C to OD600 0.4-0.5, because growth at high temperature inactivates the Salmonella restriction 664 
systems (Edwards et al., 1999). Competent cells (10-50 µL) were mixed with 10-5000 ng of DNA in 665 
electroporation cuvettes (2 mm gap) and the reactions were electroporated (2.5 kV) using a MicroPulser 666 
electroporator (Bio-Rad). Bacteria were re-suspended in 0.5-1 mL LB and incubated for recovery at 667 
37°C (30°C for temperature sensitive plasmids) with aeration, for at least one hour. Finally, the 668 
transformed bacteria were spread on selective LB agar plates and transformant colonies were obtained 669 
after at least 12 hours incubation at 30-37°C.  670 
 671 
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Cloning procedures 672 
All the plasmids and DNA oligonucleotides (primers) are listed in Supplementary Table 2. DNA 673 
manipulation and cloning procedures were carried out according to the enzyme and kit supplier 674 
recommendations and to standard procedures (Sambrook and Russell, 2001). DNA purity and 675 
concentration were measured with a DeNovix DS-11 FX spectrophotometer/fluorometer and using the 676 
Qubit dsDNA HS assay Kit. 677 
 678 
For all the cloning procedures, Polymerase Chain Reactions (PCRs) were performed with the Phusion 679 
High Fidelity DNA polymerase, purified template DNA and primers in the presence of 3 % Dimethyl 680 
Sulfoxide and 1 M betaine, when required. Prior to Sanger sequencing of the constructs, PCR reactions 681 
were carried out directly from bacteria or phages with MyTaq Red Mix 2X. PCR fragments were analysed 682 
by electrophoresis, purified and finally sequenced with the appropriate primers (Lightrun service, 683 
Eurofins Genomics) (Supplementary Table 2). 684 
 685 
All the plasmids were constructed as detailed in the Supplementary Table 2 and were verified by Sanger 686 
sequencing. Insertions of DNA fragments into plasmids were performed by digestion/ligation 687 
procedures, using restrictions enzymes and the T4 DNA ligase. In addition, PCR-driven restriction-free 688 
cloning techniques were used: overlap extension PCRs (Heckman and Pease, 2007) and plasmid 689 
assembly by PCR cloning (Van Den Ent and Löwe, 2006) were performed with chimeric primers, purified 690 
template DNA and Phusion DNA polymerase, as described previously (Owen et al., 2020). Cloning 691 
reactions were transformed by heat shock into E. coli Top10 (Invitrogen) or S17-1 λpir (Simon et al., 692 
1983). New template plasmids were constructed to insert fluorescent protein encoding genes into 693 
Salmonella or E. coli chromosomes, as reported previously (Gerlach et al., 2007). These plasmids carry 694 
the oriR6K γ origin of replication of pEMG, the frt-aph-frt (KmR) module of pKD4 linked to gfp+ (pNAW52), 695 
sfgfp (encoding for superfolder GFP, pNAW62) or mcherry (pNAW73), amplified respectively from 696 
plasmids pZEP09 (Hautefort et al., 2003), pXG10-SF (Corcoran et al., 2012) and pFCcGi (Figueira et 697 
al., 2013). A similar template plasmid, carrying the frt-aph-frt-tetR-PtetA module (pNAW55) was 698 
constructed and was used to insert the tetR repressor and the AHT-inducible promoter PtetA upstream 699 
of genes of interest, as reported earlier (Schulte et al., 2019). 700 
 701 
The high copy number plasmid pUC18 was used to clone the different versions of the anti-bstA (aba) 702 
fragment: the aba fragments (aba1-aba14 alleles) were amplified by PCR, digested with EcoRI and 703 
BamHI and ligated into the corresponding sites of pUC18. Phagemids based on the phage P22 704 
replication module were constructed by EcoRI/KpnI digestion and ligation, as follows: the PR promoter 705 
and the cro-c1-orf48-O-P genes of P22 (coordinates 31648-34683) were amplified and circularized by 706 
ligation with the aph KmR cassette of pKD4 or with the aba-aph / abamut1-aph modules, amplified from 707 
strain SNW617. The ligations reactions were purified and electroporated into ultra-competent SNW555, 708 
a prophage-free and plasmid-free derivative of S. Typhimurium D23580. The resulting phagemids 709 
pNAW229 (pP22-aph), pNAW230 (pP22-aba-aph) and pNAW231 (pP22-abamut1-aph) were obtained 710 
after selection on Km medium. 711 
 712 
Phage DNA was extracted from high titer lysates in LBO: nine volume of the phage lysates were mixed 713 
with one volume of 10 X DNase buffer (100 mM Tris-HCl, 25 mM MgCl2, pH 7.5) supplemented with 714 
RNase A (40 µg/mL final) and DNase I (400 µg/mL final). After 1 hour incubation at 37°C, DNase I was 715 
heat-inactivated at 75°C for 10 min and phage DNA was extracted from 500 µL of the nuclease-treated 716 
lysates with the Norgen Phage DNA Isolation after Proteinase K treatment, as specified by the 717 
manufacturer. 718 
 719 
Genome editing techniques 720 
Strain constructions are detailed in Supplementary Table 2. For chromosomal insertions and deletions, 721 
λ red recombination was carried out with the arabinose-inducible plasmid pKD46 (for E. coli) or with the 722 
heat inducible plasmid pSIM5-tet (for Salmonella), both expressing the λ red genes. Bacteria were grown 723 
to exponential phase in LBO, according to the resistance and induction condition of the respective λ red 724 
plasmid (Datsenko and Wanner, 2000; Hammarlöf et al., 2018; Koskiniemi et al., 2011) and electro-725 
competent cells were prepared as mentioned above. PCR fragments carrying a resistance cassette 726 
were constructed by overlap extension PCR or were directly obtained by PCR from the adequate 727 
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plasmid. Electro-competent cells (40-50 µL) were transformed with 500-5000 ng of the PCR fragments 728 
and the recombinants were selected on selective LB agar plates.  729 
 730 
Mutations or insertions linked to selective markers were transduced into Salmonella strains using the 731 
P22 HT 105/1 int-201 (P22 HT) transducing phage (Owen et al., 2017; Schmieger, 1972). For E. coli, 732 
the transducing phage P1 vir was used (Ikeda and Tomizawa, 1965; Tiruvadi Krishnan et al., 2015). 733 
Transductants were grown on selective LB agar plates supplemented with 10 mM EGTA. After two 734 
passages, clearance of the transducing phages was confirmed by diagnostic PCR using primer pairs 735 
NW_62/NW_63 for P22 HT or NW_392/NW_393 for P1 vir and by a passage on Green Agar medium 736 
(Maloy, 1990).To remove the antibiotic cassettes, flanked by FLP recognition target sites (frt), the FLP 737 
recombinase expressing plasmids pCP20, pCP20-TcR and pCP20-Gm were used, as previously 738 
reported (Cherepanov and Wackernagel, 1995; Doublet et al., 2008; Hammarlöf et al., 2018; Kintz et 739 
al., 2015). The inducible tetR-PtetA-bstA modules were constructed by fusing the frt-aph-frt-tetR-PtetA 740 
module of pNAW55 to the bstA gene of D23580 (bstABTP1, STMMW_03531), E. coli NCTC10963 (bstAEc, 741 
E4V89_RS07420) or K. pneumoniae Kp52.145 (bstAKp, BN49_1470). Each construct carries the native 742 
bstA ribosome binding site and Rho-independent terminator. The tetR-PtetA-bstA modules were inserted 743 
by λ red recombination into the STM1553 pseudogene of S. Typhimurium LT2 (between coordinates 744 
1629109-1629311), corresponding to STMMW_15481 in D23580 (coordinates 1621832-3). Previously 745 
we have shown that the STM1553 and STMMW_15481 genes are not expressed at the transcriptional 746 
level (Canals et al., 2019). 747 
 748 
In E. coli MG1655, the bstA modules were inserted into the glmS-pstS intergenic region (coordinates 749 
3911773-4). To generate Ap and Cm sensitive D23580 strains, the pSLT-BT plasmid-encoded Tn21-750 
like element, that carries the resistance genes (Kingsley et al., 2009), was replaced by the KmR cassette 751 
of pDK4 by λ red recombination (deletion coordinates 34307 to 57061, GenBank: NC_013437.1). The 752 
resulting large single-copy plasmid pSLT-BT ∆Tn21::aph was extracted (Heringa et al., 2007) and 753 
electroporated into the strains of interest. After selection on Km medium, the Ap and Cm sensitivity was 754 
confirmed and the KmR cassette was flipped out using pCP20-Gm. For scarless genome editing, the 755 
pEMG plasmid-based allelic exchange system was used (Martínez-García and de Lorenzo, 2011). The 756 
pEMG derivative suicide plasmids were constructed as specified in Supplementary Table 2 and were 757 
replicated in E. coli S17-1 λpir. Conjugation of the resulting plasmids into Salmonella and subsequent 758 
merodiploid resolution with plasmid pSW-2 were carried out as previously described (Canals et al., 2019; 759 
Owen et al., 2017). Some key strains and phages (indicated in Supplementary Table 2) used in this 760 
study were whole-genome sequenced (Illumina) at MicrobesNG (Birmingham, UK). 761 
 762 
Plasmid deletion in S. Typhimurium D23580 763 
The pSLT-BT, pBT1, pBT2 and pBT3 plasmids (Kingsley et al., 2009) were cured from strain D23580, 764 
using the CRISPR-Cas9-based methodology (Lauritsen et al., 2017). A novel CRISPR-Cas9 Km 765 
resistant plasmid (pNAW136) was obtained by ligating the CRISPR-Cas9 module of plasmid pCas9 766 
(Jiang et al., 2013) with the unstable origin of replication oriRK2, the trfA replication gene and the aph 767 
KmR gene. Anti-plasmid protospacers (30 bp) were generated by the annealing of 5’-phosphorylated 768 
primer pairs that targeted the pSLT-BT, pBT1, pBT2 and pBT3 plasmids, designed according to the 769 
Marraffini Lab protocol (Jiang et al., 2013). The protospacers were ligated into BsaI-digested pNAW136 770 
with T4 DNA ligase and the resulting plasmids were checked by Sanger sequencing, using primer 771 
NW_658. 772 
 773 
The resulting plasmids pNAW168 (anti-pSLT-BT) and pNAW169 (anti-pBT1), pNAW139 (anti-pBT2) 774 
and pNAW191 (anti-pBT3) were electroporated into D23580-derived strains and transformants were 775 
selected on Km plates. After two passages on Km, the loss of the pSLT-BT, pBT1, pBT2 or pBT3 776 
plasmids was confirmed by diagnostic PCR. The absence of the unstable pNAW136-derived plasmids 777 
was confirmed by the Km sensitive phenotype of colonies after two passages on non-selective medium. 778 
Phage stock preparation and plaque assays  779 
All phage stocks were prepared in LB or LBO. For Salmonella phages, the prophage-free strain S. 780 
Typhimurium D23580 ∆Φ (JH3949) was used as host (Owen et al., 2017). Exponential phase cultures 781 
of D23580 ∆Φ were infected with ~105 Plaque Forming Units (PFU) and infected cultures were incubated 782 
for at least 3 hours at 37°C (with aeration). Phages lysates were spun down (4,000 X g, 15 min) and 783 
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supernatants were filter-sterilized (0.22 µm, StarLab syringe filters). The resulting phage lysates were 784 
stored at 4°C in the presence 1% chloroform to prevent bacterial contamination. 785 
 786 
Coliphage lysates were prepared similarly with E. coli MG1655 as host. When required, maltose (0.2%), 787 
CaCl2 (10 mM) and MgSO4 (10 mM) were added during the infection (λ, P1 vir and Φ80pSU3+). For 788 
Φ80-derived phages, the infection temperature was reduced to 30°C (Rotman et al., 2010).  789 
 790 
Phage lysates were serial-diluted (decimal dilutions) with LB and virion enumeration was performed by 791 
double-layer overlay plaque assay (Kropinski et al., 2009), as follows. Bacterial lawns were prepared 792 
with stationary phase cultures of the reporter strains, diluted 40 times with warm Top Agar (0.5 % agar 793 
in LB, 50°C). The seeded Top Agar was poured on LB 1.5% agar bottom layer: 4 mL for 8.6 cm diameter 794 
petri dishes or 8 mL for 12 x 12 cm square plates. 795 
 796 
When inducible PtetA or PBAD constructs were present in the reporter bacteria, 500 ng/mL of AHT or 0.2 797 
% arabinose were added in the Top Agar. When required, antibiotics were added in the Top Agar layer. 798 
The bacterial lawns were incubated for 30 min at room temperature with the appropriate inducer, to 799 
allow solidification and the expression of the inducible genes. Finally, phages suspensions (5-20 µL) 800 
were applied on the Top Agar surface and pictures of the resulting plaques were taken with an 801 
ImageQuant Las 4000 imager (GE Healthcare) after 16-20 hours incubation at 30 or 37°C. 802 
 803 
Construction of P22 virulent phages 804 
For the generation of obligately virulent P22 phages, a 633 bp in-frame deletion (coordinates 31028-805 
31660) was introduced in the c2 repressor gene by λ red recombination in a P22 lysogen as follows. 806 
Two fragments of ~500 bp, flanking c2, were amplified with primers pairs NW_818 / NW_819 and 807 
NW_820 / NW_821. The two amplicons were fused by overlap extension PCR and 1000-3000 ng of the 808 
resulting Δc2 fragment were electroporated into P22 lysogens (in the prophage-free D23580 ∆Φ 809 
background) carrying the λ red recombination plasmid pSIM5-tet, as described above. The 810 
transformation reactions were re-suspended in 5 mL LB and incubated for 2 hours at 37°C with aeration. 811 
The culture supernatants were filter sterilized and serial-diluted to 10-2. Ten microliters of each dilution 812 
were mixed with 100 µL of a D23580 ∆Φ stationary phase culture and with 4 mL of warm Top Agar. The 813 
mixtures were poured on LB agar plates and the plates were incubated for ~16 hours at 37°C. P22 Δc2 814 
recombinants were identified by the clear morphology of their plaques, compared to the turbid plaques 815 
of WT P22. The Δc2 deletion was confirmed by PCR and Sanger sequencing with primers NW_406 and 816 
NW_805. 817 
 818 
Use of the Δtsp-gtrAC genetic background 819 
Where possible, experiments were carried out with native BstA expression (from its natural locus within 820 
the BTP1 prophage), to best recapitulate the natural biological activity of the protein. However, as the 821 
gtr locus of phage BTP1 blocks attachment of many phages including P22 and BTP1, to achieve efficient 822 
phage infections we consistently used a strain background where the gtr locus has been inactivated 823 
(Δtsp-gtrAC). The BTP1 prophage spontaneously induces to a titer of ~109 PFU/mL in liquid culture 824 
(Owen et al., 2017), and in the absence of gtr activity in surrounding cells, free BTP1 phages mediate 825 
cleavage of the O-antigen via the putative enzymatic activity of the tailspike protein (Kintz et al., 2015). 826 
Consequently, to avoid an unnatural, short LPS phenotype as a result of gtr inactivation in a BTP1 827 
lysogen, we additionally inactivated the upstream gene encoding for the BTP1 tailspike (tsp) (D23580 828 
Δtsp-gtrAC, JH4287). Full details of the construction of this strain can be found in the Supplementary 829 
Resource list. 830 
 831 
Phage replication assay 832 
Stationary phase cultures of the reporter bacteria were diluted to OD600 0.4 with LB. Aliquots (0.2 mL) 833 
were prepared in 1.5 mL tubes and phage stock suspensions were added to a final phage titer of 100-834 
1000 PFU/mL. The infections were carried out at 37°C (30°C for Φ80pSU3+) with shaking for 2-4 hours 835 
and were stopped by the addition of 20 µL of chloroform. After a 10 sec vortex, the lysates were 836 
centrifuged (20,000 X g, 5 min) and serial diluted. When M9 Glu+ was used, Salmonella strains were 837 
grown to OD600 ~ 0.5 in this medium prior to phage infection. 838 
 839 
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Phage titer was determined by plaque assay: 10 µL of the dilutions were applied to bacterial lawns of 840 
the appropriate reporter strain in technical triplicates. Plaques were enumerated after 16-20 hours of 841 
incubation and phage titers (PFU/mL) were calculated for each lysate. To measure the phage input at 842 
time 0 (T0), the same volume of stock phage suspension was added to 0.2 mL of bacteria-free LB and 843 
the titer was determined as described above. The fold-replication for each phage was calculated as the 844 
phage titer of the lysate post infection divided by the input phage titer at T0. When the phage titer in the 845 
lysate was lower than the phage input, the replication was considered to be null (“<1-fold). When AHT 846 
inducible tetR-PtetA-bstA strains were used, AHT (500 ng/mL) or methanol (mock) were added to the 847 
diluted bacterial suspension and phages were added after 15 min of incubation at 37°C with aeration. 848 
 849 
For replication assays of the coliphages λ, P1 vir and Φ80pSU3+, E. coli strains were grown to 850 
exponential phase (OD600 0.4) in LB and phages were added as mentioned above. To stimulate infection 851 
by these phages, maltose (0.2%), CaCl2 (10 mM) and MgSO4 (10 mM) were added during the infection 852 
and in the lawns of the reporter E. coli MG1655. All the phage replication experiments presented were 853 
carried out at least twice with biological triplicates. 854 
 855 
Induction of P22 and BTP1 prophages 856 
D23580 ∆Φ-derived lysogens that carried the different versions of P22 and BTP1 were constructed as 857 
detailed in the Supplementary Table 2. For complementation with the pUC18-derived plasmids (ApR), 858 
Ap sensitive lysogens were constructed by the inactivation of the Tn21-like element, as described 859 
above. The resulting lysogens were grown to stationary phase in LB and the pre-cultures were diluted 860 
1000 times in fresh LB and grown to OD600 0.4-0.5, prior addition of Mitomycin C (MitC, 2 µg/mL). The 861 
induced cultures were incubated for 3-5 hours at 37°C with aeration and cultures were filter sterilized 862 
and serial diluted. The phage titer was measured by plaque assay on the appropriate host strain lawn 863 
with technical replicates, as described above. Phage titers were also measured before MitC induction 864 
and the titer of the non-induced culture was subtracted from the induced titer to obtain the final phage 865 
titer. All the prophage induction experiments were carried out at least twice with biological triplicates.  866 
 867 
Survival assays 868 
For the survival assays, D23580 Δtsp-gtrAC (JH4287), D23580 Δtsp-gtrAC bstASTOP (SNW431) or 869 
D23580 ΔΦ [P22] (SSO-128) were grown in M9 Glu+ to OD600 ~0.5 and two 0.5 mL subcultures were 870 
prepared for each culture. The use of D23580 ΔΦ [P22] in these experiments controlled for the effect of 871 
lysis from without due to use of high multiplicity of infection (MOI). The strain is a lysogen for WT P22 872 
phage, and therefore is highly resistant to infection by P22-derived phages. P22 Δc2 was added at an 873 
MOI of 5. The same volume of LB was added to the two remaining subcultures (non-infected controls). 874 
Samples were incubated for 15 min at 37°C to allow phage attachment. To stop phage development, 875 
the cultures were chilled on ice and bacteria were washed with 0.5 mL of cold PBS. All the samples 876 
were serial-diluted in PBS to 10-6 and kept on ice. For the measure of survival post-infection, 10 µL of 877 
diluted infected or non-infected cultures were applied in technical triplicates on LB agar supplemented 878 
with 10 mM EGTA (EGTA was used to minimize secondary infection by free phages). Colony forming 879 
Units (CFU) were enumerated and the survival rate, was calculated as the ratio of CFUs in infected 880 
cultures divided by the CFUs obtained from non-infected cultures (in %). All the survival experiments 881 
were carried out at least twice with biological triplicates. 882 
 883 
Phage DNA detection by Southern Blotting 884 
D23580 ΔΦ tetR-PtetA-bstA (SNW576) was grown in 50 mL LB to OD600 ~0.35. The culture was split in 885 
two 20 mL sub-cultures and methanol (mock) or AHT (inducer) were added to each subculture. Bacteria 886 
were incubated to induce BstA for 20 min at 37°C and the phage of interest was added at an MOI of 5. 887 
Infections were carried out at 37°C with aeration and total DNA was extracted (Quick-DNA™ Universal 888 
Kit Zymo) from 1.5 mL of culture at 0, 10, 20, 30, 35, 40 and 50 minutes post Infection. Total DNA (100 889 
ng, according to QuBit quantification) was size-separated (2 hours at 100 V in TAE 1X) on a 0.8 % 890 
agarose-TAE gel containing Midori Green DNA staining (4 µL for 100 mL gel). One hundred nanograms 891 
of none-infected D23580 ΔΦ tetR-PtetA-bstA genomic DNA were used as a negative control. DNA was 892 
fragmented by exposing the agarose gel to UV light for 5 min on a UV-transilluminator. DNA was 893 
denatured by soaking the gel in the Denaturation Solution (0.5 M NaOH, 1.5 M NaCl) for 30 min and 894 
then in the Neutralization Solution (1.5 M NaCl, 1 M Tris-HCl, pH 7.6) for 30 min. DNA was transferred 895 
on a positively-charged Nylon membrane using the capillary blotting method. Phage DNA was detected 896 
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with DIG labelled dsDNA probes generated by PCR amplification with MyTaq DNA polymerase (Bioline), 897 
buffer, phage DNA and primers (0.4 µM each), in the presence of 0.2 mM dATP, 0.2 mM dCTP, 0.2 mM 898 
dGTP, 0.13 mM dTTP and 0.07 mM DIG-11-dUTP. For the 9NA probe a 588 bp PCR fragment was 899 
generated with primer pair NW_602 / NW_603 and for the P22/BTP1 probe a 725 bp PCR fragment 900 
was generated with primer pair SO-22 / SO-23. The DNA probes were heat-denatured at 95°C for 15 901 
min and the DNA-DNA hybridizations were carried out at 45°C for 16 hours in DIG-Easy Hyb buffer. The 902 
washing and immunodetection procedures were carried out, as specified in the DIG Application Manual 903 
for Filter Hybridization (Roche) and the chemilumiscence signal was detected using an ImageQuant 904 
LAS 4000 imager (GE Healthcare). Prior to DNA transfer onto the membrane, the Midori green-stained 905 
DNA was visualized under UV and the resulting image was used as a loading control. 906 
Phagemid efficiency of transformation 907 
To avoid a reduction in transformation caused by interference interspecies DNA modification/restriction 908 
incompatibilities between E. coli and Salmonella, all the P22-derived phagemids were replicated and 909 
extracted from S. Typhimurium SNW555. 910 
 911 
Salmonella strains carrying the tetR-PtetA-bstA module were grown in 50 mL LBO culture. When OD600 912 
~0.4 was reached, each culture was split into two 25 mL sub-cultures and methanol (mock) or AHT 913 
(inducer) were added to each subculture. Bacteria were incubated for BstA induction during 15 min at 914 
37°C. The cultures were incubated on ice for 5 min and bacteria were washed twice with cold water (25 915 
mL) and were concentrated in 0.1 mL of ice-cold sterile 10% glycerol. The OD600 of each electro-916 
competent cell sample was measured by diluting 10 µL of competent cells with 990 µL of 10% glycerol. 917 
Cell concentration was adjusted with 10% glycerol for each sample, according to the sample with the 918 
lowest OD600. The competent cells (20 µL) were mixed with 10 ng (estimated by Qubit) of the P22 919 
phagemids, pP22 (pNAW229), pP22-aba (pNAW230) or pP22-abamut1 (pNAW231) and the mixture was 920 
incubated on ice until electroporation (2.5 KV). Transformation reactions were re-suspended in 1 mL LB 921 
or 1 mL LB + AHT (for the bstA-induced bacteria) and were incubated for 60 min at 37°C, for recovery. 922 
The transformations were diluted (decimal dilution to 10-5) in LB or LB+AHT and 100 µL of each dilution 923 
(including the non-diluted sample) were spread on LB agar Km or LB agar Km+AHT plates. After 924 
incubation at 37°C, the number of KmR transformants was enumerated for each transformation and 925 
efficiency of transformation was defined as the number of transformants obtained per ng of phagemid. 926 
This experiment was performed with biological triplicates and was repeated twice with LT2 tetR-PtetA-927 
bstA (SNW389) and once with D23580 ΔΦ tetR-PtetA-bstA (SNW576), giving similar results. 928 
 929 
Microscopy- general 930 
For all imaging experiments, bacteria were sub-cultured in liquid M9 Glu+ media. All images were 931 
collected with a wide field Nikon Eclipse Ti-E inverted microscope equipped with an Okolab Cage 932 
Incubator warmed to 37°C with Cargille Type 37 immersion oil. A Nikon CFI Plan Apo DM Lambda 100X 933 
1.45 NA Oil objective and a Nikon CFI Plan Apo DM Lambda 20X .75 NA objective were used with 934 
Perfect Focus System for maintenance of focus over time. Superfolder GFP, mCherry and SYTOX 935 
Orange Nucleic Acid Stain (ThermoFisher) were excited with a Lumencor Spectra X light engine with 936 
Chroma FITC (470/24) and mCherry (575/25) filter sets, respectively and collected with a Spectra Sedat 937 
Quad filter cube ET435/26M-25 ET515/30M-25 ET595/40M-25 ET705/72M-25 and a Spectra 938 
CFP/YFP/mCherry filter cube ET475/20M-25 ET540/21M-25 ET632/60M-25. Images were acquired 939 
with an Andor Zyla 4.2 sCMOS controlled with NIS Elements software. For time-lapse experiments, 940 
images were collected every 3 minutes (unless specified otherwise) via ND acquisition using an 941 
exposure time of 100 ms and 50% or 100% illumination power for fluorescence. Multiple stage positions 942 
(fields) were collected using the default engine Ti Z. Fields best representing the overall experimental 943 
trend with the least technical artefacts were chosen for publication. Gamma, brightness, and contrast 944 
were adjusted (identically for compared image sets) using FIJI(Schindelin et al., 2012). The FIJI plug-945 
ins Stack Contrast (Capek et al., 2006) and StackReg (Thevenaz et al., 1998) were used for brightness 946 
matching and registering image stacks. 947 
 948 
Microscopy- agarose pads 949 
Agarose pads were prepared with 2% agarose and M9 Glu+ media, and mounted on MatTek dishes 950 
(No. 1.5 coverslip, 50 mm, 30 mm glass diameter, uncoated). Cells (D23580Δtsp-gtrAC (JH4287) or 951 
D23580Δtsp-gtrAC bstASTOP (SNW431) were grown to log phase (OD600 ~ 0.4) in M9 Glu+ at 37°C with 952 
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shaking (220 RPM), and where required, diluted in fresh M9 Glu+ to achieve the desired cell density on 953 
the agarose pad. For experiments where all cells were infected (Figure 4A), phage P22 Δc2 was added 954 
at an MOI of 5. Phage adsorption and initial infection was facilitated by incubation at 37°C with shaking 955 
for 10 minutes. Subsequently, infected cells were pelleted at 5000 x g and resuspended in ice-cold PBS 956 
to pause phage development. Two microliters of chilled, infected cells were spotted onto opposite sides 957 
of an agarose pad (two strains were imaged on the same pad) and inverted onto the MatTek imaging 958 
dish. Experimental MOIs were immediately confirmed by CFU and PFU /mL measurement of the cell 959 
and phage preparations. Phase-contrast images using the 100X objective were collected every 3 960 
minutes for 3 hours. 961 
  962 
Procedures for experiments involving a subset of infected cells (Figure 4C) were identical, except cells 963 
infected with P22 Δc2 p-mcherry were washed an additional 4 times in ice-cold PBS to reduce the 964 
concentration of un-adsorbed, free phage. In parallel, uninfected cells were washed once in ice-cold 965 
PBS. Infected cells were mixed at a ratio of 1:1000 with uninfected cells of the same genotype before 966 
being spotted onto the agarose pad. For these experiments, phase-contrast and fluorescence images 967 
(mCherry) using the 20X objective were collected every 3 minutes for 3 hours. 968 
 969 
Microscopy- microfluidic infection 970 
The CellASIC ONIX2 system from EMD Millipore with B04A plates was used for microfluidic imaging 971 
experiments (Figure 5). Phages used in microfluidic infection experiments shown in 5B (P22 HT or 9NA) 972 
were stained with SYTOX Orange Nucleic Acid Stain according to the protocol previously described 973 
(Valen et al., 2012). Stained phages washed 4 times in 15 mL M9 Glu+ media using Amicon Utra-15 974 
centrifugal filter units. After staining, the titer and viability of phages were immediately assessed by 975 
plaque assay, and once stained, phages were used for no longer than 2 weeks. For use in the 976 
microfluidic experiments, SYTOX Orange strained phages were normalised to a titer of approximately 977 
1010 PFU/mL. Cells (D23580 bstA-sfgfp, SNW403) were grown to early exponential phase (OD600 ~ 0.1) 978 
in M9 Glu+ at 37°C with shaking (220 RPM) before being loaded into CellASIC B04A plates using the 979 
pressure-driven method according to the manufacturer protocol for bacterial cells. The slanted chamber 980 
of the plate immobilises the cells, but allows media to flow continuously. Firstly, cells were equilibrated 981 
with constant M9 Glu+ media flow for approximately 30 minutes. Secondly, stained phages suspended 982 
in M9 Glu+ media were flowed over the cells until the majority of cells were infected (typically 10-30 983 
minutes). In the case of P22 HT phage (which exhibits inefficient adsorption to D23580 bstA-sfgfp due 984 
to the gtr locus of prophage BTP), phages were continuously flowed. Finally, M9 Glu+ media was flowed 985 
over the cells for the duration of the experiment. Microfluidic experiments typically lasted 5 hours, after 986 
which time uninfected cells outgrew the chamber. Phase-contrast and fluorescence images were 987 
collected every 1.5 minutes for the experiments in Figure 5B. 988 
 989 
For the microfluidic imaging experiments shown in Figure 5C, strain SVO251 (S. Typhimurium D23580 990 
ΔΦ STM1553::(PtetA-bstA-sfgfp-frt) ΔpSLT-BT ΔpBT1 pAW61 (PBAD-parB-mcherry) was used. This strain 991 
contains the bstA-sfgfp fusion contrast under the control of the PtetA promoter. However, this strain lacks 992 
the tetR gene, and therefore expression of bstA-sfgfp is constitutive (not inducible). Additionally, this 993 
strain is cured of two natural plasmids that contain native partitioning systems (pSLT-BT and pBT1), 994 
and there for might interfere with the correct function of the ParB-parS system used for phage DNA 995 
localization. The ParB-mCherry fusion protein is expressed from the pAW61 plasmid (ApR) under the 996 
control of the PBAD promoter (induced by L-arabinose). Strain SVO251 was grown in M9 Glu+ 997 
supplemented with 100 μg/mL ampicillin to maintain the pAW61 plasmid and 0.2% L-arabinose to induce 998 
expression of ParB-mCherry. The same supplemented media was used in the microfluidic chamber. 999 
Cells were grown to ~OD600 0.1 before loading into the CellASIC B04A plate as described above. After 1000 
15 minutes growth, phage P22 Δpid::(parS-aph) [which contains one parS site along with a kanamycin 1001 
resistance locus, aph, in place of the non-essential pid locus (Cenens et al., 2013)] diluted to a 1002 
concentration of 108 PFU/mL (in M9 Glu+ amp100 0.2% L-ara) was flowed into the chamber. Phase 1003 
contrast and red and green fluorescence images were collected every 2 minutes for 4 hours. 1004 
 1005 
BstA protein homolog analysis 1006 
BstA protein homologs were identified using tblastn (database: non-redundant nucleotide collection) 1007 
and the HMMER webserver (Potter et al., 2018) (database: Reference Proteomes). The dataset of BstA 1008 
protein homologs was manually curated to reflect the diversity of taxonomic background harbouring 1009 
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homologs. To analyse the genetic context of BstA homologs, the sequence region 20 Kb either side of 1010 
the homolog (40 kb total) was extracted (BstA 40 kb neighbourhoods). To produce homogenous and 1011 
comparable annotations, each region was re-annotated using Prokka 1.13 (Seemann, 2014). 1012 
Additionally, the resulting annotated amino acid sequences were queried against our custom BstA 1013 
profile-hmm and the Pfam 31.0 database (El-Gebali et al., 2019) with hmmerscan (Eddy, 1998), and the 1014 
highest scoring significant hit per ORF was considered for the results shown in Figure 2. All the code is 1015 
available in https://github.com/baymLab/2020_Owen-BstA.  1016 
 1017 
Pairwise identity of homologs in Figure 2B to BstABTP1 was computed using the EMBOSS Needle 1018 
webserver (Needleman and Wunsch, 1970). BstA homologs were designated “putatively-prophage 1019 
associated” if annotated genes in the 40 kb neighbourhood contained any instance or the word “phage” 1020 
or “terminase”. For categorisation in Figure 2C, homologs were classed as having “high confidence 1021 
association” if instances of gene annotations including the aforementioned key words occurred both 1022 
before, and after, the BstA gene within the 40 Kb neighbourhood (i.e., to account for the possibility that 1023 
a prophage-independent homolog could co-occur next to a prophage region by chance). Homologs 1024 
classed as having “low confidence association” had at least one instance of genes whose annotations 1025 
included “phage” or “terminase” either in the upstream or downstream 20Kb, but not both. Plasmid status 1026 
was determined from information in the sequence records. The HHpred webserver was used to annotate 1027 
the putative KilA-N domain (Zimmermann et al., 2018). All homolog neighbourhoods, homolog 1028 
alignments and sequences is available to download https://github.com/baymLab/2020_Owen-BstA. 1029 
 1030 
QUANTIFICATION AND STATISTICAL ANALYSES 1031 
The phage replication, survival rate, efficiencies of transformation and of lysogeny were calculated as 1032 
mentioned above. The numerical data were plotted and analyzed using GraphPad Prism 8.4.1. Unless 1033 
stated otherwise in the figure legends, data are presented as the mean of biological triplicates ± standard 1034 
deviation. The unpaired t-test was used to compare the groups and statistical significance is indicated 1035 
on the figures. P values are reported using the following criteria: < 0.0001 = ****, 0.0001 to 0.001 = ***, 1036 
0.001 to 0.01 = **, 0.01 to 0.05 = *, ≥ 0.05 = ns.  1037 
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KEY RESOURCES TABLE 1038 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
Anti-Digoxigenin-AP, Fab fragments (Roche) MilliporeSigma Cat#00000001109327
4910 
Bacterial and Virus Strains  
All the bacterial strains and bacteriophages are listed and 
described in Supplementary Table 2 
  
Chemicals, Peptides, and Recombinant Proteins 
L-(+)-arabinose Melford Cat#A51000-100.0 
Betaine MilliporeSigma Cat#B2629 
Bacto Agar (BD) Appleton Woods Cat#MN663 
Bacto Casamino Acids Technical (BD) Appleton Woods Cat#223110 
EGTA MilliporeSigma Cat#E3889 
M9 Salts 5X MilliporeSigma Cat#M6030 
Maltose MilliporeSigma Cat#M5885 
m-toluic acid MilliporeSigma Cat#T36609 
Tryptone (BD) Appleton Woods Cat#MN649 
Yeast Extract (BD) Appleton Woods Cat#DM832 
Ampicillin Sodium Melford Cat#A40040-25.0 
Anhydrotetracycline hydrochloride (AHT) MilliporeSigma Cat#37919 
Chloramphenicol MilliporeSigma Cat#C0378 
Gentamicin sulfate Melford Cat#G38000-25.0 
Kanamycin monosulfate Melford Cat#K22000-25.0 
Mitomycin C  MilliporeSigma Cat#M0503 
Tetracycline hydrochloride MilliporeSigma Cat#T7660 
EcoRI ThermoFisher Scientific Cat#ER0271 
BamHI ThermoFisher Scientific Cat#ER0051 
DpnI New England Biolabs Cat#R0176S 
KpnI-HF New England Biolabs Cat#R3142S 
BsaI-HF New England Biolabs Cat#R3535S 
SmaI ThermoFisher Scientific Cat#ER0661 
SalI ThermoFisher Scientific Cat#ER0641 
XbaI New England Biolabs Cat#R0145S 
T4 Polynucleotide Kinase ThermoFisher Scientific Cat#EK0031 
T4 DNA ligase ThermoFisher Scientific Cat#EL0014 
CutSmart buffer New England Biolabs Cat#B7204S 
Tango Buffer 10X ThermoFisher Scientific Cat#BY5 
T4 DNA ligase Reaction Buffer New England Biolabs Cat#B0202S 
Phusion High Fidelity DNA polymerase New England Biolabs Cat#M0530S 
MyTaq Red PCR mix 2X Bioline Cat#BIO-25043 
Taq DNA polymerase Bioline Cat#BIO-21105 
DNase I MilliporeSigma Cat#DN25 
RNase A MilliporeSigma Cat#R6513 
Proteinase K Bioline Cat#BIO-37037 
dNTP mix Bioline Cat#BIO-39025 
dATP Bioline Cat#BIO-39036 
dGTP Bioline Cat#BIO-39037 
dCTP Bioline Cat#BIO-39038 
dTTP Bioline Cat#BIO-39039 
DIG-11-dUTP, alkali-stable (Roche) MilliporeSigma Cat#11093088910 
Midori Green DNA/RNA staining Nippon Genetics Cat#MG06 
Electroporation cuvettes Geneflow Cat#E6-0060 
Nylon membrane, positively charged (Roche) MilliporeSigma Cat#11417240001 
.CC-BY-NC 4.0 International license(which was not certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprintthis version posted July 13, 2020. . https://doi.org/10.1101/2020.07.13.199331doi: bioRxiv preprint 
Blocking Reagent (Roche) MilliporeSigma Cat#11096176001 
DIG Easy HybTM Granules (Roche) MilliporeSigma Cat#11796895001 
Critical Commercial Assays 
ISOLATE II Plasmid Mini Kit Bioline Cat#BIO-52057 
ISOLATE II PCR and Gel Kit Bioline Cat#BIO-52060 
Norgen Phage DNA Isolation Kit (46850) GeneFlow Cat#P4-0134 
Quick-DNA™ Universal Kit Zymo Cat#D4069 
Invitrogen Qubit dsDNA HS Assay Kit ThermoFisher Scientific Cat#Q32851 
SYTOX Orange Nucleic Acid Stain – 5 mM in DMSO ThermoFisher Scientific Cat#S11368 
Amicon Ultra-15 centrifugal filter units MilliporeSigma Cat#UFC910024 
Oligonucleotides 




All the plasmids are listed and described in Supplementary 
Table 2 
  
Software and Algorithms 
GraphPad Prism 8.4.1   
HMMER webserver https://www.ebi.ac.uk/Tools/hmmer/ 
Prokka 1.13   
HHPred webserver https://toolkit.tuebingen.mpg.de/tools/hhpred 
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Figure legends & Supplementary Materials 1254 
 1255 
 1256 
Supplementary Table 1: Details of all BstA homologs used in the analysis presented in Figure 2. 1257 
 1258 
Supplementary Table 2: Details of all oligonucleotide sequences, plasmids, bacterial strains and  1259 
phages used in this study. 1260 
 1261 
Supplementary Video 1: Cells natively expressing BstA (D23580 Δtsp-gtrAC, JH4287) or possessing 1262 
a mutated BstA locus (D23580 Δtsp-gtrAC bstASTOP, SNW431) were infected with the obligately virulent 1263 
P22-derivate phage, P22Δc2, at an MOI of 5 (to increase the likelihood of infecting all cells). Infected 1264 
cells were imaged every 3 minutes on agarose pads. Regardless of BstA function, almost all cells were 1265 
observed to lyse (indicated by loss of defined cell shape and phase contrast). 1266 
 1267 
Supplementary Video 2: Cells natively expressing BstA (D23580 Δtsp-gtrAC, JH4287) or possessing 1268 
a mutated BstA locus (D23580 Δtsp-gtrAC bstASTOP, SNW431) were infected with the obligately virulent 1269 
P22-derivate phage, P22Δc2 p-mcherry, at an MOI of 5 (to increase the likelihood of infecting all cells). 1270 
Due to the mcherry insertion, red fluorescence corresponds to phage replication. Infected cells were 1271 
mixed 1:1000 with uninfected cells. Cells mixtures were imaged every 5 minutes on agarose pads for 6 1272 
hours. In the BstA+ cells, primary infected cells lysed, but did not stimulate secondary infections of 1273 
neighbouring cells, and eventually formed a confluent lawn. In BstA- cells, primary lysis events caused 1274 
secondary infections (neighbouring cells showing red fluorescence and subsequent lysis) causing an 1275 
epidemic of phage infection reminiscent of plaque formation. 1276 
 1277 
Supplementary Video 3: Cells natively expressing BstA translationally fused to sfGFP (D23580 bstA-1278 
sfgfp, SNW403) were grown in a microfluidic growth chamber and imaged every 1.5 minutes. 1279 
Fluorescently labelled phages P22 HT (left) or 9NA (right) were then added to the cells, and can be 1280 
seen adsorping to cells as red fluorescent puncta. For purposes of comparison, timestamps are 1281 
synchronised to the point at which phage are first observed. Typically around 20 minutes after initial 1282 
observation of phage infection, BstA proteins formed discrete and dynamic foci within the. Cells then 1283 
proceeded to lyse. 1284 
 1285 
Supplementary Video 4: Cells heterologously expressing BstA translationally fused to sfGFP, and ParB 1286 
translationally fused to mCherry (D23580 ΔΦ ΔpSLT_BT ΔpBT1 STMMW_15481::[PtetA-bstABTP1-1287 
sfgfp-frt] pAW61, SVO251) were grown in a microfluidic growth chamber and imaged every 2 minutes. 1288 
Phage P22 ∆pid::(parS-aph) were then added to the cells. ParB protein oligomerises onto DNA at parS 1289 
sites, and therefore parS-tagged DNA is indicated by ParB-mCherry foci (red). Translocation of infecting 1290 
phage DNA is indicated by the formation of red foci within the cells, which is rapidly followed by formation 1291 
of green, BstA foci. The green and red foci appear to physically overlap. Infected cells proceed to lyse. 1292 
The same timeseries is presented as separate channels (phase contrast, GFP, mCherry), and a 1293 
composite merge.  1294 
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Supplementary Figure 1: The bstA locus confers phage resistance and bstA nonsense mutations supresses the phage 1295 
resistance phenotype 1296 
(A) P22 HT (P22 HT 105/1 int-201) replication assay on S. Typhimurium D23580 WT, or ΔBTP1, ΔbstA, bstASTOP, Δtsp-1297 
gtrAC and Δtsp-gtrAC bstASTOP mutants (strain JH3877, SSO-204, SSO-78, JH4287 and SNW431, respectively). Replication 1298 
was measured 3 hours post-infection and phages were enumerated on lawns of D23580 Δtsp-gtrAC bstASTOP (SNW431). (B) 1299 
Replication assays of the indicated phages were carried with mock-induced (BstA-) or AHT-induced (BstA++) strains LT2 1300 
tetR-PtetA-bstABTP1 (JH4400) or LT2 tetR-PtetA-bstASTOP (JH4402, carrying two nonsense mutations in bstA), as host. Phage 1301 
replication was measured 2-3 hours post infection and phages were enumerated on lawns of LT2 WT. Phage replication 1302 
(log10-transformed folds) is presented as the mean of biological triplicates ± SD. ND = Replication not-detected. (C) 1303 
Nonsense mutations in bstA suppress the BstA-driven anti-phage phenotype. Plaque assay were carried out with the 1304 
indicated phages on mock- or AHT-induced lawns of LT2 tetR-PtetA-bstASTOP (JH4402).1305 
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Supplementary Figure 2: Extended alignment of BstA protein homologs showing all columns and strain names 
Blue boxes indicate columns which are gaps relative to the reference sequence (top row, BstA from S. Typhimurium D23580), and are collapsed in the alignment shown in Figure 2. Grey box 
indicates the position of the putative KilA-N domain. 
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Supplementary Figure 3: BstA homologs confer phage resistance in S. Typhimurium LT2 and E. coli MG1655 1307 
(A) BstAKp and BstAEc confer phage resistance in S. Typhimurium. (B) BstABTP1 and BstAEc confer phage resistance in E. coli.1308 
Phage replication assays were carried out with mock-induced (BstA-) or AHT-induced (BstA++) cultures of LT2 tetR-PtetA-bstAEc 1309 
(JH4408), LT2 tetR-PtetA-bstAKp (JH4404), MG1655 tetR-PtetA-bstABTP1 (JH4410) or MG1655 tetR-PtetA-bstAEc (JH4414), 1310 
infected with the indicated phage. LT2 or MG1655 WT lawns were used for phage enumerate 2-3 hours post infection. Phage 1311 
replication (log10-transformed folds) is presented as the mean of biological triplicates ± SD. ND = Replication not-detected. 1312 
When replication difference between induced and non-induced cultures was lower than one order of magnitude, groups were 1313 
compared using unpaired two-tailed Student t-test and P values and significance are indicated by *,**,*** or ns (not significant). 1314 
(C) BstAEc confers phage resistance to E. coli. Plaque assay were carried out with the indicated phages applied on a lawn of1315 
mock- or AHT-induced MG1655 tetR-PtetA-bstAEc (JH4414). 1316 
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Supplementary Figure 4: C-terminal Superfolder GFP (sfGFP) fusion to BstA does not impair the BstA anti-phage 1317 
activity 1318 
Replication assays were carried with the indicated phages on strains carrying the WT bstA (bstAWT, strain D23580 in panel A, 1319 
the defective bstASTOP version (strain SSO-78) or the BstA-sfGFP fusion strain (bstA-sfgfp, strain SNW403). Phage replication 1320 
was measured 3 hours post-infection and plaques were enumerated on lawns of D23580 Δtsp-gtrAC bstASTOP (SNW431). 1321 
Phage replication is presented on a log10 scale as the mean of biological triplicates ± SD.  1322 
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Supplementary Figure 5: Identification of the anti-BstA (aba) factor 
(A) BTP1 bstA locus truncations revealed the location of the anti-bstA fragment aba. The bstA truncations are indicated for each BTP1 variant. The bstAΔ allelic numbering corresponds to 
the number of base pairs remaining from the bstA ATG start. (B) Transfer of the bstAΔ34 fragment in P22 confers BstA-immunity. Fragments bstAΔ34I- bstAΔ34V are indicated. The donor strain 
for each BTP1 and P22 variant is indicated in brackets. The residual scar sequence of pKD4 is indicated by frt and hairpins represent rho-independent terminators. Plaque assays were 
performed with the indicated BTP1/P22-derived phages on lawns of mock-induced (BstA-) or AHT-induced (BstA++) LT2 tetR-PtetA-bstABTP1 (JH4400). 
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 Supplementary Figure 6: Multiple copies of aba DNA suppresses BstA activity in trans 
(A) The aba sequence was cloned into the pUC18 plasmid in either orientation, and the plasmids were transformed into LT2 tetR-PtetA-bstABTP1 (JH4400). Plaques assays were performed 
with phage P22 and 9NA applied on lawns of mock-induced (BstA-) or AHT-induced (BstA++) LT2 tetR-PtetA-bstABTP1 (JH4400), transformed with the indicated plasmid. Both plasmids 
(pUC18-aba1 and pUC18-aba2) supressed BstA activity and permitted plaque formation by P22 and 9NA in the presence of BstA. (B) When a single nucleotide mutation was made in either 
of the terminal CCCGCC motifs, the pUC18 aba plasmids could not rescue the replication of P22 or 9NA in the presence of BstA. (C) Analysis of the aba sequence: putative open reading 
frames (ORFs) encoding for peptides longer that 6 amino acids are shown. All the ATG, TTG or GTG triplets were considered as putative start codons. The mutations of the functional aba10 
and aba11 (shown in A) and the resulting mutated residues (in red) in the putative ORFs are indicated. Stop codons are indicated by *. Non-synonymous mutation in the putative ORFs does 
not disrupt aba suppression of BstA, therefore aba is unlikely to function via a peptide. (D) Transcription of aba does not counteract the BstA anti-phage activity. The aba sequence was 
inserted in both direction in the chromosome of strain D23580 ΔΦ tetR-PtetA-bstABTP1 (strains SNW618 and SNW619), downstream of the native arabinose-inducible promoter PBAD (bended 
arrow) controlled by the AraC regulatory protein. Plaques assays were performed with the indicated phages and strains in the presence or absence of L-arabinose (0.2%). Induction of the 
transcription of aba by L-arabinose did not suppress the activity of BstA (P22 and 9NA phage plaquing is inhibited). (E) Further mutational disruption was made to the aba sequence cloned 
into pUC18 plasmids, to identify regions of the sequence that are essential for aba function. All mutations to pUC18 aba were non-functional (i.e. not capable of BstA suppression) except 
for the aba12 derivative. Plaques assays were performed with phage P22 and 9NA applied on lawns of mock-induced (BstA-) or AHT-induced (BstA++) LT2 tetR-PtetA-bstABTP1 (JH4400), 
transformed with the indicated plasmid. 
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